SECURITIES PURCHASE AGREEMENT, dated as of March 8, 2007 (this
"Agreement"), among EURONET WORLDWIDE, INC., a Delaware corporation
(the "Company"), and the Purchasers listed on Exhibit A hereto,
together with their permitted transferees (each, a "Purchaser" and
collectively, the "Purchasers").
---------------------------------------------------------------------
INTRODUCTION
------------
The Company and the Purchasers are executing and delivering this
Agreement in reliance upon the exemption from securities registration afforded
by Section 4(2) of the Securities Act and Rule 506 of Regulation D promulgated
thereunder.
The Purchasers desire to purchase and the Company desires to sell,
upon the terms and conditions stated in this Agreement, shares of the Company's
common stock, par value $.02 per share (the "Common Stock").
The capitalized terms used herein and not otherwise defined have the
meanings given them in Article VII.
In consideration of the premises and the mutual covenants contained
herein and other good and valuable consideration, the receipt and sufficiency of
which are hereby acknowledged, the Company and the Purchasers (severally and not
jointly) hereby agree as follows:
ARTICLE I
PURCHASE AND SALE OF SHARES
---------------------------
Section 1.1 Purchase and Sale of Shares. At the Closing, the Company
will issue and sell to each Purchaser, and each Purchaser will, severally and
not jointly, purchase from the Company the number of shares of Common Stock (the
"Shares") set forth opposite such Purchaser's name on Exhibit A hereto. The
purchase price for each Share shall be $25.00 (the "Purchase Price"), which
represents a discount of approximately 7.7% to the closing bid price of the
Common Stock as reported on NASDAQ (symbol "EEFT") as the 4:00 p.m. EST closing
bid price on March 7, 2007.
Section 1.2 Payment. At the Closing, each Purchaser will pay the
aggregate Purchase Price set forth opposite its name on Exhibit A hereto by wire
transfer of immediately available funds in accordance with wire instructions
provided by the Company to the Purchasers prior to the Closing. At or promptly
following the Closing, the Company will instruct its transfer agent to deliver
stock certificates to the Purchasers representing the Shares against delivery of
the aggregate Purchase Price on the Closing Date.
Section 1.3 Closing Date. The closing of the transaction contemplated
by this Agreement will take place on or about March 12, 2007 (the "Closing
Date") and the closing (the "Closing") will be held at the offices of Xxxxxxx
Xxxxxxxx Xxxxxx LLP, 0000 Xxxxxx, Xxxxx 0000, Xxxxxx Xxxx, Xxxxxxxx 00000, or at
such other time and place as shall be agreed upon by
the Company and the Purchasers hereunder of a majority in interest of the
aggregate number of Shares purchased hereunder.
ARTICLE II
REPRESENTATIONS AND WARRANTIES OF THE COMPANY
---------------------------------------------
The Company hereby represents and warrants to the Purchasers that:
Section 2.1 Organization and Qualification; Subsidiaries. Each of the
Company and its subsidiaries is duly incorporated, validly existing and in good
standing under the laws of the jurisdiction of its organization, with corporate
power and authority to conduct its business as currently conducted as disclosed
in the SEC Documents. Each of the Company and its subsidiaries is duly qualified
to do business and is in good standing in every jurisdiction in which the nature
of the business conducted by it or property owned by it makes such qualification
necessary, except where the failure to be so qualified or in good standing, as
the case may be, would not reasonably be expected, individually or in the
aggregate, to have a Material Adverse Effect. The only corporations,
associations or other entities currently majority owned or controlled, directly
or indirectly, by the Company are the entities listed in Exhibit 21.1 to the
Company's Annual Report on Form 10-K for the fiscal year ended December 31,
2006.
Section 2.2 Authorization; Enforcement. The Company has all requisite corporate
power and authority to enter into and to perform its obligations under this
Agreement, to consummate the transactions contemplated hereby and to issue the
Shares in accordance with the terms hereof. The execution, delivery and
performance of this Agreement by the Company and the consummation by it of the
transactions contemplated hereby (including the issuance of the Shares) have
been duly authorized by the Company's Board of Directors and no further consent
or authorization of the Company, its Board of Directors, or its stockholders is
required. This Agreement has been duly executed by the Company and constitutes
a legal, valid and binding obligation of the Company enforceable against the
Company in accordance with its terms, except as enforceability may be limited
by applicable bankruptcy, insolvency, reorganization, or moratorium or similar
laws affecting creditors' and contracting parties' rights generally and except
as enforceability may be subject to general principles of equity and except as
rights to indemnity and contribution may be limited by state or federal
securities laws or public policy underlying such laws.
Section 2.3 Capitalization. The authorized capital stock of the
Company, as of February 23, 2007, consisted of (a) 90,000,000 shares of Common
Stock, of which 37,733,605 shares were issued and outstanding and (b) 10,000,000
shares of Preferred Stock, $0.02 par value per share, none of which have been
issued. All of the issued and outstanding shares of Common Stock have been duly
authorized, validly issued, fully paid, and nonassessable. As of February 23,
2007, options to purchase an aggregate of 2,195,740 shares of Common Stock were
outstanding, the Company had obligations to issue 1,038,675 shares of unvested
restricted Common Stock upon vesting and 8,486,618 shares of Common Stock were
reserved for issuance upon conversion of the Company's outstanding convertible
debentures. Except as disclosed in or contemplated by the SEC Documents, the
Company does not have outstanding any options to purchase, warrants, or any
preemptive rights or other rights to subscribe for or to purchase, any
securities or obligations convertible into or exchangeable
2
for, or any contracts or commitments to issue or sell, shares of its capital
stock or any such options, rights, convertible securities or obligations other
than options granted under the Company's stock option plans and its employee
stock purchase plan.
Section 2.4 Issuance of Shares. The Shares are duly authorized and,
upon issuance in accordance with the terms of this Agreement, will be validly
issued, fully paid and non-assessable and shall be free from all taxes, liens
and charges (excluding taxes, liens or charges created by or through the
Purchaser) and will not be subject to preemptive rights or other similar rights
of stockholders of the Company. No co-sale right, right of first refusal or
other similar right exists with respect to the Shares or the issuance and sale
thereof. The issue and sale of the Shares will not result in a right of any
holder of Company securities to adjust the exercise, conversion, exchange or
reset price under such securities.
Section 2.5 No Conflicts; Government Consents and Permits. (a) The
execution, delivery and performance of this Agreement by the Company and the
consummation by the Company of the transactions contemplated hereby (including
the issuance of the Shares) will not (i) conflict with or result in a violation
of any provision of its certificate of incorporation or bylaws or require the
approval of the Company's stockholders, (ii) violate or conflict with, or result
in a breach of any provision of, or constitute a default under, any agreement,
indenture, or instrument to which the Company or any of its subsidiaries is a
party, or (iii) result in a violation of any law, rule, regulation, order,
judgment or decree (including United States federal and state securities laws
and regulations and regulations of any self-regulatory organizations to which
the Company or its securities are subject) applicable to the Company or any of
its subsidiaries, except in the case of clauses (ii) and (iii) only, for such
conflicts, breaches, defaults, and violations as would not reasonably be
expected, individually or in the aggregate, to have a Material Adverse Effect.
(b) The Company is not required to obtain any consent, authorization
or order of, or make any filing or registration with, any court or governmental
agency or any regulatory or self regulatory agency or any other Person in order
for it to execute, deliver or perform any of its obligations under this
Agreement in accordance with the terms hereof, or to issue and sell the Shares
in accordance with the terms hereof other than such as have been made or
obtained, and except for the registration of the Shares under the Securities Act
pursuant to Section 6 hereof, any filings required to be made under federal and
state securities laws, and any required filings or notifications regarding the
issuance or listing of additional shares with Nasdaq.
(c) Each of the Company and its subsidiaries has all franchises,
permits, licenses, and any similar authority necessary for the conduct of its
business as now being conducted by it, except for such franchise, permit,
license or similar authority, the lack of which would not reasonably be
expected, individually or in the aggregate, to have a Material Adverse Effect.
Neither of the Company nor its subsidiaries has received any notice of any
proceeding relating to revocation or modification of any such franchise, permit,
license, or similar authority except where such revocation or modification would
not reasonably be expected, individually or in the aggregate, to have a Material
Adverse Effect.
Section 2.6 SEC Documents, Financial Statements. (a) The Company has
timely filed all reports, schedules, forms, statements and other documents
required to be filed by
3
it with the SEC during the 24 months preceding the date of this Agreement,
pursuant to the reporting requirements of the Exchange Act (all of the foregoing
filed prior to the date hereof and all exhibits included therein and financial
statements and schedules thereto and documents (other than exhibits)
incorporated by reference therein, being hereinafter referred to herein as the
"SEC Documents"). As of their respective dates, the SEC Documents complied as to
form in all material respects with the requirements of the Exchange Act, and the
rules and regulations of the SEC promulgated thereunder applicable to the SEC
Documents, and none of the SEC Documents, at the time they were filed with the
SEC, contained any untrue statement of a material fact or omitted to state a
material fact required to be stated therein or necessary in order to make the
statements therein, in light of the circumstances under which they were made,
not misleading. The Financial Statements have been prepared in accordance with
accounting principles generally accepted in the United States, consistently
applied, during the periods involved (except (i) as may be otherwise indicated
in the Financial Statements or the notes thereto, or (ii) in the case of
unaudited interim statements, to the extent they may not include footnotes, may
be condensed or summary statements or may conform to the SEC's rules and
instructions for Reports on Form 10-Q) and fairly present in all material
respects the consolidated financial position of the Company as of the dates
thereof and the consolidated results of its operations and cash flows for the
periods then ended (subject, in the case of unaudited statements, to normal and
recurring year-end audit adjustments). There is no material transaction,
arrangement, or other relationship between the Company and an unconsolidated or
other off balance sheet entity that is required to be disclosed by the Company
in its Exchange Act filings and is not so disclosed. All material agreements
that were required to be filed as exhibits to the Annual Report on Form 10-K for
the fiscal year ended December 31, 2006 under Item 601 of Regulation S-K
(collectively, the "Material Agreements") to which the Company or any of its
subsidiaries are a party, or to which the property or assets of the Company or
any of its subsidiaries are subject, have been filed or incorporated by
reference as exhibits to the Annual Report on Form 10-K for the fiscal year
ended December 31, 2006. Each of the Company and its subsidiaries is not in
breach of or default under any of the Material Agreements to which it is a
party, and to the Company's Knowledge, no other party to a Material Agreement is
in breach of or default under such Material Agreement, except, in each case, for
such breaches or defaults as would not reasonably be expected, individually or
in the aggregate, to have a Material Adverse Effect. Neither the Company nor any
of its subsidiaries has received a written notice of termination of any of the
Material Agreements. Except with respect to the matters covered by the
Confidentiality Agreement executed by the applicable Purchaser, the Company
confirms that neither it nor any person acting on its behalf has provided any
Purchaser or its agents or counsel with any information that the Company
believes constitutes material, non-public information. The Company understands
and confirms that each Purchaser will rely on the foregoing representation in
effecting transactions in securities of the Company.
(b) As of the date hereof the Company is a well-known seasoned issuer
(a "WKSI") and is not an ineligible issuer, each as defined in Rule 405 under
the Securities Act. The Company meets the requirements for the use of Form S-3
for the registration of the resale of the Shares by the Purchasers.
Section 2.7 Absence of Litigation. As of the date hereof, there is no
action, suit or proceeding before or by any court, public board, government
agency, self-regulatory
4
organization or body pending or, to the Company's Knowledge, threatened against
the Company or any of its subsidiaries that, if determined adversely would
reasonably be expected, individually or in the aggregate, to have a Material
Adverse Effect. To the Knowledge of the Company, as of the date hereof, there is
no investigation before or by any court, public board, government agency,
self-regulatory organization or body pending or threatened against the Company
or any of its subsidiaries that, if determined adversely would reasonably be
expected, individually or in the aggregate, to have a Material Adverse Effect.
To the Knowledge of the Company, there is not pending any investigation by the
SEC involving the Company or any current or former director or officer of the
Company. The Company has not received any stop order or other order suspending
the effectiveness of any registration statement filed by the Company under the
Exchange Act or the Securities Act and, to the Company's Knowledge, the SEC has
not issued any such order.
Section 2.8 Intellectual Property Rights. Each of the Company and its
subsidiaries owns or possesses licenses or sufficient rights to use the
inventions (patented and non-patented), know-how, trade secrets, trademarks,
trademark applications, service marks, service names, trade names and copyrights
and any other material intellectual property that it is currently using and that
are necessary to enable it to conduct its business as conducted as of the date
hereof (the "Intellectual Property"), except for such Intellectual Property the
lack of which could not reasonably be expected, individually or in the
aggregate, to result in a Material Adverse Effect. Except as disclosed in the
SEC Documents, neither the Company nor any of its subsidiaries has infringed the
intellectual property rights of third parties and no third party, to the
Company's Knowledge and except as disclosed in the SEC Documents, is infringing
the Intellectual Property, in each case, which could reasonably be expected,
individually or in the aggregate, to result in a Material Adverse Effect. Except
as disclosed in the SEC Documents, there are no material options, licenses or
agreements relating to the Intellectual Property, nor is the Company or any of
its subsidiaries bound by or a party to any material options, licenses or
agreements relating to the patents, patent applications, patent rights,
inventions, know-how, trade secrets, trademarks, trademark applications, service
marks, service names, trade names or copyrights of any other person or entity.
As of the date hereof, there is no material claim or action or proceeding
pending or, to the Company's Knowledge, threatened, that challenges the right of
the Company or any of its subsidiaries with respect to any Intellectual
Property. The Company and its subsidiaries have taken reasonable security
measures to protect the secrecy, confidentiality and value of all of their
Intellectual Property.
Section 2.9 Placement Agent. The Company has taken no action that
would give rise to any claim by any person for brokerage commissions, placement
agent's fees or similar payments relating to this Agreement or the transactions
contemplated hereby, except for dealings with the Placement Agent, whose
commissions and fees will be paid by the Company.
Section 2.10 Investment Company. The Company is not and, after giving
effect to the offering and sale of the Shares, will not be an "investment
company" as such term is defined in the Investment Company Act of 1940, as
amended.
Section 2.11 No Material Adverse Effect. Since December 31, 2006,
except as described or referred to in the SEC Documents and except for cash
expenditures in the ordinary course of business, there has not been any change
in the business, financial condition, results of
5
operations, its assets or liabilities except for any such change that would not
reasonably be expected to result, individually or in the aggregate, in a
Material Adverse Effect. No event, liability or development has occurred or
exists with respect to the Company or its subsidiaries or their respective
business, properties, operations or financial condition, that would be required
to be disclosed by the Company under applicable securities laws at the time this
representation is made that has not been publicly disclosed at least one trading
day prior to the date that this representation is made.
Section 2.12 Nasdaq Global Select Market. The issued and outstanding
shares of Common Stock are listed on Nasdaq, and, to the Company's Knowledge,
there are no proceedings to revoke or suspend such listing. The Company is in
compliance in all material respects with the requirements of Nasdaq for
continued listing of the Common Stock thereon and any other Nasdaq listing and
maintenance requirements and has no knowledge of any facts or circumstances that
would reasonably lead to delisting or suspension of the Common Stock by Nasdaq
in the foreseeable future.
Section 2.13 Acknowledgment Regarding Purchasers' Purchase of Shares.
The Company acknowledges and agrees that each of the Purchasers is acting solely
in the capacity of an arm's length purchaser with respect to this Agreement and
the transactions contemplated hereby. The Company further acknowledges that no
Purchaser is acting as a financial advisor or fiduciary of the Company (or in
any similar capacity with respect to the Company), with respect to this
Agreement and the transactions contemplated hereby and any advice given by any
Purchaser or any of their respective representatives or agents to the Company in
connection with this Agreement and the transactions contemplated hereby is
merely incidental to such Purchaser's purchase of the Shares. The Company
further represents to each Purchaser that the Company's decision to enter into
this Agreement has been based upon the independent evaluation of the
transactions contemplated hereby by the Company and its representatives.
Section 2.14 Accountants. KPMG LLP, who have expressed their opinion
with respect to the audited financial statements and schedules that will be
included as a part of the Registration Statement, are independent accountants as
required by the Securities Act.
Section 2.15 Insurance. Each of the Company and its Material
Subsidiaries is insured by insurers of recognized financial responsibility
against such losses and risks and in such amounts as the Company believes are
prudent for a company (i) in the businesses and location in which the Company or
the Material Subsidiary, as applicable, is engaged, and (ii) with the resources
of the Company or the Material Subsidiary, as applicable, as applicable. Neither
the Company nor any of the Material Subsidiaries has received any notice that it
will not be able to renew its existing insurance coverage as and when such
coverage expires. The Company and its Material Subsidiaries have not received
any notice that the Company will not be able to renew its existing insurance
coverage at a reasonable cost as and when such coverage expires.
Section 2.16 Foreign Corrupt Practices. Neither the Company nor any of
its subsidiaries nor, to the Company's Knowledge, any director, officer, agent,
employee or other person acting on behalf of the Company or any of its
subsidiaries has, in the course of its actions for, or on behalf of, the Company
or any subsidiary, (i) used any corporate funds for any
6
unlawful contribution, gift, entertainment or other unlawful expenses relating
to political activity; (ii) made any direct or indirect unlawful payment to any
foreign or domestic government official or employee from corporate funds; (iii)
violated or is in violation of any provision of the U.S. Foreign Corrupt
Practices Act of 1977, as amended; or (iv) made any unlawful bribe, rebate,
payoff, influence payment, kickback or other unlawful payment to any foreign or
domestic government official or employee; except in the cases of clauses (i),
(ii) and (iv) only, as would not reasonably be expected, individually or in the
aggregate, to have a Material Adverse Effect.
Section 2.17 Private Placement. Neither the Company nor any person
acting on its or their behalf, has, directly or indirectly, made any offers or
sales of any security or solicited any offers to buy any security, under any
circumstances that would require registration of the Shares under the Securities
Act; provided that no representation or warranty is made pursuant to this
Section 2.17 with respect to the Placement Agent. None of the Company, its
subsidiaries, any of their affiliates, or any Person acting on their behalf has,
directly or indirectly, made any offers or sales of any security or solicited
any offers to buy any security, under circumstances that would require
registration of any of the Shares under the Securities Act or cause this
offering of the Shares to be integrated with prior offerings by the Company for
purposes of the Securities Act or any applicable stockholder approval
provisions, including, without limitation, under the rules and regulations of
Nasdaq.
Section 2.18 No Registration Rights. No person has the right to (i)
prohibit the Company from filing the Registration Statement or (ii) other than
as disclosed in the SEC Documents, require the Company to register any
securities for sale under the Securities Act by reason of the filing of the
Registration Statement. The granting and performance of the registration rights
under this Agreement will not violate or conflict with, or result in a breach of
any provision of, or constitute a default under, any agreement, indenture or
instrument to which the Company is a party.
Section 2.19 Application of Takeover Protections. Assuming that no
Purchaser will become an Interested Stockholder within the meaning of Section
203 of the Delaware General Corporation Law or become an Acquiring Person within
the meaning of the Company's stockholder rights plan as result thereof, the
execution and delivery of this Agreement and the consummation of the
transactions contemplated hereby will not impose any restriction on any
Purchaser, or create in any party (including any current stockholder of the
Company) any rights, under any share acquisition, business combination, poison
pill (including any distribution under a rights agreement), or other similar
anti-takeover provisions under the Company's charter documents or the laws of
its state of incorporation.
Section 2.20 Xxxxxxxx-Xxxxx Act. The Company is in material compliance
with all applicable provisions of the U.S. Xxxxxxxx-Xxxxx Act of 2002 that are
effective and the rules and regulations promulgated in connection therewith.
Section 2.21 Internal Accounting Controls. The Company maintains (i)
effective internal control over financial reporting as defined in Rule 13a-15
under the Securities Exchange Act of 1934, as amended, and (ii) a system of
internal accounting controls sufficient to provide reasonable assurance that (A)
transactions are executed in accordance with
7
management's general or specific authorizations; (B) transactions are recorded
as necessary to permit preparation of financial statements in conformity with
generally accepted accounting principles and to maintain asset accountability;
(C) access to assets is permitted only in accordance with management's general
or specific authorization; and (D) the recorded accountability for assets is
compared with the existing assets at reasonable intervals and appropriate action
is taken with respect to any differences. The Company maintains disclosure
controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the
Exchange Act) that are designed to provide reasonable assurance that information
required to be disclosed in the Company's reports under the Exchange Act is
recorded, processed, summarized and reported within the time periods specified
in the rules and forms of the SEC, and that such information is accumulated and
communicated to the Company's management, including its Chief Executive Officer
and Chief Financial Officer, as appropriate, to allow timely decisions regarding
required disclosures.
Section 2.22 Taxes. The Company and each of its subsidiaries has
timely filed (or has obtained an extension of time within which to file) all
necessary federal, state and foreign income and franchise tax returns and has
paid all taxes shown as due on such tax returns, except where the failure to so
file or the failure to so pay would not reasonably be expected to have a
Material Adverse Effect.
Section 2.23 No Manipulation of Stock. The Company has not, and to its
knowledge no one acting on its behalf has, taken, nor will it take, directly or
indirectly, any action designed to stabilize or manipulate the price of the
Common Stock or any security of the Company to facilitate the sale or resale of
any of the Shares.
Section 2.24 Related Party Transactions. Except with respect to
transactions (i) that are not required to be disclosed and (ii) contemplated
hereby to the extent any director or executive officer or an Affiliate of any
director or executive officer purchases Securities hereunder, all transactions
that have occurred between or among the Company, on the one hand, and any of its
executive officers or directors, or any Affiliate or Affiliates of any such
officer or director, on the other hand, prior to the date hereof have been
disclosed in the SEC Documents.
Section 2.25 Disclosure. The representations and warranties of the
Company contained herein are true and correct in all material respects and do
not contain any untrue statement of a material fact or omit to state any
material fact necessary in order to make the statements made therein, in the
light of the circumstances under which they were made, not misleading.
Section 2.26 U.S. Real Property Holding Corporation. The Company is
not, nor has it ever been, a U.S. real property holding corporation within the
meaning of Section 897 of the Internal Revenue Code of 1986, as amended.
Section 2.27 Insolvency. The Company and its subsidiaries,
individually and on a consolidated basis, are not as of the date hereof, and
after giving effect to the transactions contemplated hereby to occur at the
Closing, will not be Insolvent (as defined below). For purposes of this Section.
"Insolvent" means, with respect to any Person (i) the present fair saleable
value of the such Person's assets is less than the amount required to pay such
Person's
8
total indebtedness, (ii) such Person is unable to pay its debts and liabilities,
subordinated, contingent or otherwise, as such debts and liabilities become
absolute and matured, (iii) such Person intends to incur or believes that it
will incur debts that would be beyond its ability to pay as such debts mature,
or (iv) such Person has unreasonably small capital with which to conduct the
business in which it is engaged as such business is now conducted and is
proposed to be conducted.
Section 2.28 Title. The Company and its subsidiaries have good and
marketable title to all real property and good title to all personal property
owned by them which is material to the business of the Company and its
subsidiaries, in each case free and clear of all liens, encumbrances and
defects, except for such liens, encumbrances and defects as are disclosed in the
SEC Documents, or arise under the credit facilities that have been entered into
by the Company and its subsidiaries, or as would not reasonably be expected,
individually or in the aggregate, to result in a Material Adverse Effect. Any
real property and facilities held under lease by the Company and any of its
subsidiaries are held by them under valid, subsisting and enforceable leases
with such exceptions as would not reasonably be expected, individually or in the
aggregate, to result in a Material Adverse Effect.
Section 2.29 Environmental Laws. The Company and its subsidiaries (i)
are in compliance with any and all Environmental Laws (as hereinafter defined),
(ii) have received all permits, licenses or other approvals required of them
under applicable Environmental Laws to conduct their respective businesses and
(iii) are in compliance with all terms and conditions of any such permit,
license or approval where, in each of the foregoing clauses (i), (ii) and (iii),
the failure to so comply could be reasonably expected to have, individually or
in the aggregate, a Material Adverse Effect. The term "Environmental Laws" means
all federal, state, local or foreign laws relating to pollution or protection of
human health or the environment (including, without limitation, ambient air,
surface water, groundwater, land surface or subsurface strata), including,
without limitation, laws relating to emissions, discharges, releases or
threatened releases of chemicals, pollutants, contaminants, or toxic or
hazardous substances or wastes (collectively, "Hazardous Materials") into the
environment, or otherwise relating to the manufacture, processing, distribution,
use, treatment, storage, disposal, transport or handling of Hazardous Materials,
as well as all authorizations, codes, decrees, demands or demand letters,
injunctions, judgments, licenses, notices or notice letters, orders, permits,
plans or regulations issued, entered, promulgated or approved thereunder.
Section 2.30 Employee Relations. Except as disclosed in the SEC
Documents, neither the Company nor any of its Subsidiaries is a party to any
collective bargaining agreement. Except as disclosed in the SEC Documents, no
executive officer of the Company has notified the Company that such executive
officer intends to leave the Company or otherwise terminate such executive
officer's employment with the Company. The Company and its subsidiaries are in
compliance with all federal, state, local and foreign laws and regulations
respecting labor, employment and employment practices and benefits, terms and
conditions of employment and wages and hours, except where failure to be in
compliance would not, either individually or in the aggregate, reasonably be
expected to result in a Material Adverse Effect.
Section 2.31 Subsidiary Rights. Except as set forth in the SEC
Documents and except as provided in the credit facilities entered into by the
Company and its subsidiaries, the
9
Company or one of its subsidiaries has the right to vote, and (subject to
limitations imposed by applicable law) to receive dividends and distributions
on, all capital securities of its subsidiaries as owned by the Company or such
subsidiary.
Section 2.32 Acknowledgement Regarding Purchasers' Trading Activity.
It is understood and acknowledged by the Company that, except as provided in
Section 3.11 and subject to compliance by the Purchasers with applicable law,
(i) none of the Purchasers have been asked by the Company or its Subsidiaries to
agree, nor has any Purchaser agreed with the Company or its Subsidiaries, to
desist from purchasing or selling, long and/or short, securities of the Company,
or "derivative" securities based on securities issued by the Company or to hold
the Shares for any specified term; (ii) any Purchaser, and counterparties in
"derivative" transactions to which any such Purchaser is a party, directly or
indirectly, presently may have a "short" position in the Common Stock, and (iii)
each Purchaser shall not be deemed to have any affiliation with or control over
any arm's length counterparty in any "derivative" transaction. The Company
further understands and acknowledges that, subject to compliance by the
Purchasers with applicable law, one or more Purchaser may engage in hedging
and/or trading activities at various times during the period that the Shares are
outstanding and (b) such hedging and/or trading activities, if any, can reduce
the value of the existing stockholders' equity interest in the Company both at
and after the time the hedging and/or trading activities are being conducted.
The Company acknowledges that such aforementioned hedging and/or trading
activities do not constitute a breach of this Agreement, or any of the documents
executed in connection herewith.
ARTICLE III
PURCHASER'S REPRESENTATIONS AND WARRANTIES
------------------------------------------
Each Purchaser represents and warrants to the Company, severally and
not jointly, with respect to itself and its purchase hereunder, that:
Section 3.1 Investment Purpose. The Purchaser is purchasing the Shares
for its own account and not with a present view toward the public sale or
distribution thereof and has no intention of selling or distributing any of such
Shares or any arrangement or understanding with any other persons regarding the
sale or distribution of such Shares except in accordance with the provisions of
Article VI or except as would not result in a violation of the Securities Act.
The Purchaser will not, directly or indirectly, offer, sell, pledge, transfer or
otherwise dispose of (or solicit any offers to buy, purchase or otherwise
acquire or take a pledge of) any of the Shares (including hedging in respect
thereof) except in accordance with the provisions of Article VI or pursuant to
and in accordance with the Securities Act.
Section 3.2 Questionnaires. Purchaser has submitted to the Company a
Purchaser Questionnaire and a Registration Statement notice and questionnaire
substantially in the form of Exhibit B hereto and such questionnaire shall be
accurate and correct when delivered and as of the Closing Date.
Section 3.3 Reliance on Exemptions. The Purchaser understands that the
Shares are being offered and sold to it in reliance upon specific exemptions
from the registration requirements of United States federal and state securities
laws, including Section 4(2) of the
10
Securities Act and Rule 506 of Regulation D thereunder and that the Company is
relying upon the truth and accuracy of, and the Purchaser's compliance with, the
representations, warranties, agreements, acknowledgments and understandings of
the Purchaser set forth herein in order to determine the availability of such
exemptions and the eligibility of the Purchaser to acquire the Shares.
Section 3.4 Information. The Purchaser has had the opportunity to
review the SEC Documents. At a reasonable time prior to the Offering, the
Purchaser has been afforded the opportunity to ask questions and receive answers
concerning the terms and conditions of the Offering and to obtain any additional
information which the Company possesses or can acquire without unreasonable
effort or expense that is necessary to verify the accuracy of the information
contained in the SEC Documents. Neither such inquiries nor any other
investigation conducted by or on behalf of such Purchaser or its representatives
or counsel shall modify, amend or affect such Purchaser's right to rely on the
truth, accuracy and completeness of the SEC Documents and the Company's
representations and warranties contained herein.
Section 3.5 Acknowledgement of Risk. (a) The Purchaser acknowledges
and understands that its investment in the Shares involves a significant degree
of risk, including, without limitation, (i) an investment in the Company is
speculative, and only Purchasers who can afford the loss of their entire
investment should consider investing in the Company and the Shares; (ii) the
Purchaser may not be able to liquidate its investment; (iii) transferability of
the Shares is limited; (iv) in the event of a disposition of the Shares, the
Purchaser could sustain the loss of its entire investment; (v) the Company has
not paid any dividends on its Common Stock since inception and does not
anticipate the payment of dividends in the foreseeable future and (vi) the "Risk
Factors" included in the Company's Annual Report on Form 10-K for the year ended
December 31, 2006. Such risks are more fully set forth in the SEC Documents;
(b) The Purchaser is an "accredited investor" as defined in Rule
501(a) of Regulation D under the Securities Act. The Purchaser is able to bear
the economic risk of holding the Shares for an indefinite period, and has
knowledge and experience in financial and business matters such that it is
capable of evaluating the risks of the investment in the Shares; and
(c) The Purchaser has, in connection with the Purchaser's decision to
purchase Shares, not relied upon any representations or other information
(whether oral or written) other than as set forth in the representations and
warranties of the Company contained herein, and the Purchaser has, with respect
to all matters relating to this Agreement and the offer and sale of the Shares,
relied solely upon the advice of such Purchaser's own counsel and has not relied
upon or consulted any counsel to the Placement Agent or counsel to the Company.
Section 3.6 Governmental Review. The Purchaser understands that no
United States federal or state agency or any other government or governmental
agency has passed upon or made any recommendation or endorsement of the Shares
or an investment therein.
11
Section 3.7 Transfer or Resale. The Purchaser understands that:
(a) the Shares have not been and are not being registered under the
Securities Act (other than as contemplated in Article VI) or any applicable
state securities laws and, consequently, the Purchaser may have to bear the risk
of owning the Shares for an indefinite period of time because the Shares may not
be transferred unless (i) the resale of the Shares is registered pursuant to an
effective registration statement under the Securities Act, as contemplated in
Article VI; (ii) the Purchaser has delivered to the Company an opinion of
counsel (in form, substance and scope reasonably satisfactory to the Company) to
the effect that the Shares to be sold or transferred may be sold or transferred
pursuant to an exemption from such registration; or (iii) the Shares are sold or
transferred pursuant to Rule 144;
(b) any sale of the Shares made in reliance on Rule 144 may be made
only in accordance with the terms of Rule 144 and, if Rule 144 is not
applicable, any resale of the Shares may require compliance with some other
exemption under the Securities Act or the rules and regulations of the SEC
thereunder; and
(c) except as set forth in Article VI, neither the Company nor any
other person is under any obligation to register the resale of the Shares under
the Securities Act or any state securities laws or to comply with the terms and
conditions of any exemption thereunder.
Section 3.8 Legends. (a) The Purchaser understands the certificates
representing the Shares will bear a restrictive legend in substantially the
following form (and a stop-transfer order may be placed against transfer of the
certificates for such Shares) while a legend is required on such Shares:
THE SHARES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED
UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES LAWS OF ANY
STATE OF THE UNITED STATES. THE SHARES MAY NOT BE SOLD, OFFERED FOR SALE,
PLEDGED, HYPOTHECATED, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF AN EFFECTIVE
REGISTRATION STATEMENT FOR THE SHARES UNDER APPLICABLE SECURITIES LAWS, OR
UNLESS OFFERED, SOLD, PLEDGED, HYPOTHECATED OR TRANSFERRED PURSUANT TO AN
AVAILABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THOSE LAWS. THE
COMPANY SHALL BE ENTITLED TO REQUIRE AN OPINION OF COUNSEL SATISFACTORY TO THE
COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED. NOTWITHSTANDING THE FOREGOING,
THE SHARES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER
LOAN OR FINANCING ARRANGEMENT SECURED BY THE SHARES TO THE EXTENT EXEMPT FROM
REGISTRATION UNDER THE SECURITIES ACT.
Section 3.9 Authorization; Enforcement. The Purchaser has all
requisite power and authority to enter into this Agreement, to perform its
obligations hereunder and to consummate the transactions contemplated hereby.
The Purchaser has taken all necessary action to authorize the execution,
delivery and performance of this Agreement. This Agreement has been duly
executed by the Purchaser and constitutes a valid and binding obligation of the
Purchaser enforceable in accordance with its terms, except as enforceability may
be limited by
12
applicable bankruptcy, insolvency, reorganization, moratorium or similar laws
affecting creditors' and contracting parties' rights generally and except as
enforceability may be subject to general principles of equity and except as
rights to indemnity and contribution may be limited by state or federal
securities laws or public policy underlying such laws.
Section 3.10 Residency. The Purchaser is a resident of the
jurisdiction set forth immediately below such Purchaser's name on the signature
pages hereto.
Section 3.11 No Transactions. Between the time the Purchaser learned
about the Offering and the public announcement or public disclosure of the
Offering pursuant to Section 4.4, the Purchaser has not engaged in any
transactions with respect to the Common Stock, nor has the Purchaser, directly
or indirectly, caused any Person to engage in any transactions with respect to
the Common Stock.
Section 3.12 Acknowledgements Regarding Placement Agent. (a) The
Purchaser acknowledges that the Placement Agent is acting as the exclusive
placement agent on a "best efforts" basis for the Shares being offered hereby
and will be compensated by the Company for acting in such capacity. The
Purchaser represents that (i) the Purchaser has a pre-existing relationship with
the Placement Agent, (ii) the Purchaser was contacted regarding the sale of the
Shares by the Placement Agent (or an authorized agent or representative thereof)
with whom the Purchaser entered into a confidentiality agreement and (iii) no
Shares were offered or sold to it by means of any form of general solicitation
or general advertising.
(b) The Purchaser acknowledges that the Placement Agent and its
directors, officers, employees, representatives and controlling persons have no
responsibility for making any independent investigation of the Company's SEC
Documents and make no representation or warranty to the Purchaser, express or
implied, with respect to the Company or the Shares or the accuracy, completeness
or adequacy of the Company's SEC Documents or any other publicly available
information, nor shall any of the foregoing persons be liable for any loss or
damages of any kind resulting from the use of the information contained therein
or otherwise supplied to the Purchaser. In addition, the Purchaser acknowledges
that it has not relied on information provided by any of such persons but has
conducted its own investigation.
Section 3.13 Review of Schedule 1. The Purchaser acknowledges receipt
and review of the information set forth in Schedule 1.
ARTICLE IV
COVENANTS
---------
Section 4.1 Reporting Status. The Company's Common Stock is registered
under Section 12 of the Exchange Act. During the Registration Period, the
Company agrees to use commercially reasonable efforts to timely (or within the
periods permitted under Rule 12b-25 of the Exchange Act) file with the SEC all
reports required to be so filed under the Exchange Act, and the Company will not
terminate its status as an issuer required to file reports under the Exchange
Act even if the Exchange Act or the rules and regulations thereunder would
permit such termination.
13
Section 4.2 Expenses. The Company and each Purchaser is each severally
and not jointly liable for, and each will pay, its own expenses incurred in
connection with the negotiation, preparation, execution and delivery of this
Agreement, including, without limitation, attorneys' and consultants' fees and
expenses.
Section 4.3 Information. (a) The Company agrees that the financial
statements of the Company to be included in any documents filed with the SEC
will be prepared in accordance with accounting principles generally accepted in
the United States, consistently applied (except (i) as may be otherwise
indicated in such financial statements or the notes thereto, or (ii) in the case
of unaudited interim statements, to the extent they may not include footnotes,
may be condensed or summary statements or may conform to the SEC's rules and
instructions for Reports on Form 10-Q), and will fairly present in all material
respects the consolidated financial position of the Company and consolidated
results of its operations and cash flows as of, and for the periods covered by,
such financial statements (subject, in the case of unaudited statements, to
normal and recurring year-end audit adjustments).
(b) The Company covenants and agrees that neither it nor any other
Person acting on its behalf will provide any Purchaser or its agents or counsel
with any information that the Company believes constitutes material non-public
information, unless prior thereto such Purchaser shall have executed a written
agreement regarding the confidentiality and use of such information after the
date hereof. The Company understands and confirms that each Purchaser shall be
relying on the foregoing representations in effecting transactions in securities
of the Company.
Section 4.4 Securities Laws Disclosure; Publicity. On or before 9:30
a.m., New York local time, on March 8, 2007 the Company shall issue a press
release or Form 8-K announcing the signing of this Agreement and describing the
material terms of the transactions contemplated by this Agreement, including the
contemplated use of proceeds. The Company acknowledges that, after the filing of
such Form 8-K or issuance of such press release, the Purchasers will no longer
be in possession of material non-public information regarding the Company or the
Offering that has been provided by or on behalf of the Company. On or before
March 12, 2007, the Company shall file a Current Report on Form 8-K with the SEC
describing the terms of the transactions contemplated by this Agreement and the
contemplated use of proceeds and including as an exhibit to such Current Report
on Form 8-K this Agreement, in the form required by the Exchange Act. The
Company shall not publicly disclose any information concerning a Purchaser
without the prior written consent of such Purchaser, except for disclosure of
the name of such Purchaser and the type and amount of securities of the Company
held by such Purchaser in connection with any legal or regulatory filings
required to be made by the Company or except as otherwise required by law.
Section 4.5 Sales by Purchasers. Each Purchaser will sell any Shares
held by it in compliance with applicable prospectus delivery requirements, if
any, or otherwise in compliance with the requirements for an exemption from
registration under the Securities Act and the rules and regulations promulgated
thereunder.
Section 4.6 Pledge of Shares. The Company acknowledges and agrees that
the Shares may be pledged by a Purchaser in connection with a bona fide margin
agreement or
14
other loan or financing arrangement that is secured by the Shares. The pledge of
Shares shall not be deemed to be a transfer, sale or assignment of the Shares
hereunder, and no Purchasers effecting a pledge of the Shares shall be required
to provide the Company with any notice thereof or otherwise make any delivery to
the Company pursuant to this Agreement; provided that a Purchaser and its
pledgee shall comply with the provisions of this Agreement in order to effect a
sale, transfer, or assignment of any such Shares to such pledgee. At the expense
of the Purchaser pledging such Shares, the Company hereby agrees to execute and
deliver such documentation as pledgee of the Shares may reasonably request in
connection with a pledge of the Shares to such pledgee by a Purchaser.
Section 4.7 Removal of Legend. The Purchaser may request that the
Company remove, and the Company agrees to authorize the removal of any legend
from the Shares (i) following any sale of the Shares pursuant to an effective
Registration Statement or Rule 144, (ii) while a registration statement covering
the resale of such security is effective under the Securities Act (provided,
however, that the Purchaser's prospectus delivery requirements under the
Securities Act will remain), or (iii) if such Shares are eligible for sale under
Rule 144(k). Following the time a legend is no longer required for the Shares
hereunder, the Company will promptly following the delivery by a Purchaser to
the Company's transfer agent of a legended certificate representing such
securities with notice to the Company, deliver or cause to be delivered to such
Purchaser a certificate representing such securities that is free from all
restrictive and other legends. The Company shall cause its counsel to issue a
legal opinion to the Company's transfer agent promptly after the effective date
of any registration statement (the "Effective Date") if required by the
Company's transfer agent to effect the removal of the legend hereunder. The
Company agrees that following the Effective Date or at such time as such legend
is no longer required under clause (ii) above, it will, no later than three
trading days following the delivery by any Purchaser to the Company's transfer
agent of a certificate representing Shares issued with a restrictive legend with
notice to the Company, deliver or cause to be delivered to such Purchaser a
certificate representing such Shares that is free from all restrictive and other
legends. The Company may not make any notation on its records or give
instructions to any transfer agent of the Company that enlarge(s) the
restrictions on transfer set forth herein. If within three trading days after
the receipt by the Company's transfer agent of a legended certificate
representing such Shares (the "Delivery Date"), the Company shall fail to issue
and deliver to such Purchaser a certificate representing such Shares that is
free from all restrictive and other legends, and if on or after such Delivery
Date the Purchaser purchases (in an open market transaction or otherwise) shares
of Common Stock ("Covering Shares") to deliver in satisfaction of a sale by the
Purchaser of Shares ("Sold Shares") that the Purchaser anticipated receiving
from the Company without any restrictive legend, then the Company shall, within
three trading days after the Purchaser's request, pay to the Purchaser in
immediately available funds an amount equal to the number of Sold Shares
multiplied by the excess, if any, of (x) the Purchaser's total purchase price
per share (including brokerage commissions, if any) for the Covering Shares over
(y) the net proceeds per share (after brokerage commissions, if any) received by
the Purchaser from the sale of the Sold Shares.
15
ARTICLE V
CONDITIONS TO CLOSING
---------------------
Section 5.1 Conditions to Obligations of the Company. The Company's
obligation to complete the purchase and sale of the Shares and deliver such
stock certificate(s) to each Purchaser is subject to the fulfillment or waiver
as of the Closing Date of the following conditions:
(a) Receipt of Funds. The Company shall have received immediately
available funds in the full amount of the purchase price for the Shares being
purchased hereunder from Purchasers acquiring 90% of the aggregate Shares set
forth on Exhibit A hereto.
(b) Representations and Warranties. The representations and warranties
made by each Purchaser in Article III shall be true and correct in all material
respects, except such representations and warranties that are qualified by
materiality or Material Adverse Effect which must be true and correct in all
respects, as if they had been made on and as of such date, except that the
accuracy of representations and warranties that by their terms speak as of a
specified date will be determined as of such date.
(c) Covenants. All covenants, agreements and conditions contained in
this Agreement to be performed by the Purchasers on or prior to the Closing Date
shall have been performed or complied with in all material respects.
(d) Blue Sky. The Company shall have obtained all necessary blue sky
law permits and qualifications, or secured exemptions therefrom, required by any
state for the offer and sale of the Shares.
(e) Absence of Litigation. No proceeding challenging this Agreement or
the transactions contemplated hereby, or seeking to prohibit, alter, prevent or
materially delay the Closing, shall have been instituted or be pending before
any court, arbitrator, governmental body, agency or official.
(f) No Governmental Prohibition. The sale of the Shares by the Company
shall not be prohibited by any law or governmental order or regulation.
(g) No Stop Order. No stop order or suspension of trading shall have
been imposed by Nasdaq, the SEC or any other governmental or regulatory body
with respect to public trading in the Common Stock.
Section 5.2 Conditions to Purchasers' Obligations at the Closing. Each
Purchaser's obligation to complete the purchase and sale of the Shares is
subject to the fulfillment or waiver as of the Closing Date of the following
conditions:
(a) Representations and Warranties. The representations and warranties
made by the Company in Article II that are qualified by materiality (including
in the definition of Material Adverse Effect) shall be true and correct in all
respects as of the Closing Date as if they had been made on and as of such date
and the representations and warranties made by the Company in Article II that
are not so qualified shall be true and correct in all material respects
16
as if they had been made on and as of such date, except that the accuracy of
representations and warranties that by their terms speak as of a specified date
will be determined as of such date.
(b) Covenants. All covenants, agreements and conditions contained in
this Agreement to be performed by the Company on or prior to the Closing Date
shall have been performed or complied with in all material respects.
(c) Blue Sky. The Company shall have obtained all necessary blue sky
law permits and qualifications, or secured exemptions therefrom, required by any
state or foreign or other jurisdiction for the offer and sale of the Shares.
(d) Legal Opinion. The Company shall have delivered to such Purchaser
an opinion, dated as of the Closing Date, from (i) Xxxxxxx Xxxxxxxx Xxxxxx LLP,
counsel to the Company, and (ii) the General Counsel of the Company, in
substantially the forms attached hereto as Exhibit C-1 and Exhibit C-2,
respectively.
(e) Certificates of the Company. The Company shall have delivered to
such Purchaser (i) a certificate of a senior executive officer of the Company,
dated the Closing Date, confirming the satisfaction of the conditions set forth
in clauses (a) and (b) of this Section 5.2, (ii) a certificate of the Secretary
or Assistant Secretary of the Company, dated the Closing Date, certifying as to
the incumbency and signatures of the officers executing this Agreement and the
other documents delivered by the Company under this Agreement and (iii) a good
standing certificate of the Company, dated as of a recent date, from the
Secretary of State of the State of Delaware.
(f) Transfer Agent Instructions. The Company shall have delivered to
its transfer agent irrevocable instructions to issue to such Purchaser or in
such nominee name(s) as designated by such Purchaser in writing one or more
certificates representing such number of Shares set forth opposite such
Purchaser's name on Exhibit A hereto.
(g) Absence of Litigation. No proceeding challenging this Agreement or
the transactions contemplated hereby, or seeking to prohibit, alter, prevent or
materially delay the Closing, shall have been instituted or be pending before
any court, arbitrator, governmental body, agency or official.
(h) No Governmental Prohibition. The sale of the Shares by the Company
shall not be prohibited by any law or governmental order or regulation.
(i) No Stop Order. No stop order or suspension of trading shall have
been imposed or threatened by Nasdaq, the SEC or any other governmental or
regulatory body with respect to public trading in the Common Stock.
(j) Outstanding Shares. The Company shall have delivered to the
Purchasers a letter from the Company's transfer agent certifying the number of
shares of Common Stock outstanding as of a date within five days of the Closing
Date.
(k) Listed. The Common Stock shall be designated for quotation or
listed on Nasdaq, subject to official notice of issuance.
17
ARTICLE VI
REGISTRATION RIGHTS
-------------------
Section 6.1 Filing of Registration Statement. The Company shall use
its reasonable best efforts to (i) file with the SEC and have declared effective
a registration statement pursuant to Rule 415 under the Securities Act (the
"Registration Statement") covering the resale of the Registrable Securities no
later than 30 days after the Closing Date (the "Filing Date"), provided that to
the extent then available to the Company, such Registration Statement shall be
an automatic shelf registration statement on Form S-3 and (ii) effect the
registration, qualifications or compliances (including, without limitation, the
execution of any required undertaking to file post-effective amendments,
appropriate qualifications or exemptions under applicable blue sky or other
state securities laws and appropriate compliance with applicable securities
laws, requirements or regulations) as promptly as practicable after the filing
thereof.
Section 6.2 Expenses. All Registration Expenses incurred in connection
with any registration, qualification, exemption or compliance pursuant to
Section 6.1 shall be borne by the Company. All Selling Expenses relating to the
sale of securities registered by or on behalf of any Holder shall be borne by
such Holder.
Section 6.3 Registration Defaults. The Company further agrees that, in
the event that the Registration Statement (i) has not been filed with the SEC
and declared effective within 30 days after the Closing Date or (ii) after the
Registration Statement is declared effective by the SEC, is suspended by the
Company or ceases to remain continuously effective as to all Registrable
Securities for which it is required to be effective, other than, in each case,
within the time period(s) permitted by Section 6.7(b) (each such event referred
to in clauses (i) and (ii), a "Registration Default"), for any thirty-day period
(a "Penalty Period") during which the Registration Default remains uncured
(which initial thirty-day period shall commence on the fifth Business Day after
the date of such Registration Default if such Registration Default has not been
cured by such date), the Company shall pay in cash to each Purchaser 1% of such
Purchaser's aggregate Purchase Price for such Purchaser's Registrable Securities
then held by such Purchaser that are not then permitted to be sold pursuant to
the Registration Statement for each Penalty Period during which the Registration
Default remains uncured; provided, however, that if a Purchaser fails to provide
the Company with any information that is required to be provided in the
Registration Statement with respect to such Purchaser as set forth herein, then
the commencement of the Penalty Period with respect to such Purchaser described
above shall be extended until such time as the Company fails to comply with
Section 6.4(k); provided further, that the amount payable to any Holder
hereunder for any partial Penalty Period shall be prorated for the number of
actual days during such Penalty Period during which a Registration Default
remains uncured; and provided further, that in no event shall the Company be
required to pay to any Purchaser pursuant to this Section 6.3 an aggregate
amount that exceeds 10% of the aggregate Purchase Price paid by such Purchaser
for such Purchaser's Registrable Securities. The amount set forth above shall be
the exclusive monetary remedy available to the Holders of Registrable Securities
for each Registration Default or a breach of this Agreement that also
constitutes a Registration Default (or would constitute a Registration Default
except for Section 6.7(b)).
18
Section 6.4 Registration Period Covenants. In the case of the
registration, qualification, exemption or compliance effected by the Company
pursuant to this Agreement, the Company shall, upon reasonable request, inform
each Holder as to the status of such registration, qualification, exemption and
compliance. At its expense, during the Registration Period, the Company shall:
(a) except for such times as the Company is permitted hereunder to
suspend the use of the prospectus forming part of the Registration Statement,
use its commercially reasonable efforts to keep such registration, and any
qualification, exemption or compliance under state securities laws that the
Company determines to obtain, continuously effective with respect to a Holder
(including, filing any necessary post-effective amendment to the Registration
Statement) and to keep such Registration Statement free of any material
misstatements or omissions, until the earlier of the following: (i) the second
anniversary of the Closing Date, (ii) the date on which all Registrable
Securities held by such Holder may be sold under Rule 144(k) or (iii) the date
that all of the Registrable Securities have been sold by the Holder. The period
of time during which the Company is required hereunder to keep the Registration
Statement effective is referred to herein as the "Registration Period";
(b) advise the Holders:
(i) within two Business Days when the Registration Statement
or any amendment thereto has been filed with the SEC and when the
Registration Statement or any post-effective amendment thereto has
become effective;
(ii) within five Business Days of any request by the SEC
following the effectiveness of the Registration Statement for
amendments or supplements to the Registration Statement or the
prospectus included therein or for additional information;
(iii) within five Business Days of the issuance by the SEC
of any stop order suspending the effectiveness of the Registration
Statement or the initiation of any proceedings for such purpose;
(iv) within five Business Days of the receipt by the Company
of any notification with respect to the suspension of the
qualification of the Registrable Securities included therein for sale
in any jurisdiction or the initiation or threatening of any proceeding
for such purpose; and
(v) within five Business Days of the occurrence of any event
that requires the making of any changes in the Registration Statement
or the prospectus so that, as of such date, the Registration Statement
and prospectus do not contain an untrue statement of material fact and
do not omit to state a material fact required to be stated therein or
necessary to make the statements therein (in the case of the
prospectus, in the light of the circumstances under which they were
made) not misleading;
(c) use its best efforts to obtain the withdrawal of any order
suspending the effectiveness of any Registration Statement as soon as reasonably
practicable;
19
(d) promptly deliver to each such Holder, without charge, as many
copies of the prospectus included in such Registration Statement and any
amendment or supplement thereto as such Holder may reasonably request in
writing; and the Company consents to the use, consistent with the provisions
hereof, of the prospectus or any amendment or supplement thereto by each of the
selling Holders of Registrable Securities in connection with the offering and
sale of the Registrable Securities covered by the prospectus or any amendment or
supplement thereto;
(e) if a Holder so requests in writing, deliver to each Holder,
without charge, other than those documents available via XXXXX, (i) one copy of
the following documents: (A) its annual report to its stockholders, if any
(which annual report shall contain financial statements audited in accordance
with generally accepted accounting principles in the United States of America by
a firm of certified public accountants of recognized standing), (B) if not
included in substance in its annual report to stockholders, its annual report on
Form 10-K (or similar form), (C) its definitive proxy statement with respect to
its annual meeting of stockholders, (D) each of its quarterly reports to its
stockholders, and, if not included in substance in its quarterly reports to
stockholders, its quarterly report on Form 10-Q (or similar form), and (E) a
copy of the full Registration Statement (the foregoing, in each case, excluding
exhibits); and (ii) if explicitly requested, all exhibits excluded by the
parenthetical to the immediately preceding clause (E);
(f) prior to any public offering of Registrable Securities pursuant to
any Registration Statement, promptly take such actions as may be necessary to
register or qualify or obtain an exemption for offer and sale under the
securities or blue sky laws of such United States jurisdictions as any such
Holders reasonably request in writing, provided that the Company shall not for
any such purpose be required to qualify generally to transact business as a
foreign corporation in any jurisdiction where it is not so qualified, to consent
to general service of process in any such jurisdiction or subject itself to
taxation in any jurisdiction that it is not now subject, and do any and all
other acts or things reasonably necessary or advisable to enable the offer and
sale in such jurisdictions of the Registrable Securities covered by such
Registration Statement;
(g) upon the occurrence of any event contemplated by Section 6.4(b)(v)
above, except for such times as the Company is permitted hereunder to suspend
the use of the prospectus forming part of the Registration Statement, the
Company shall use its commercially reasonable efforts to as soon as reasonably
practicable prepare a post-effective amendment to the Registration Statement or
a supplement to the related prospectus, or file any other required document so
that, as thereafter delivered to purchasers of the Registrable Securities
included therein, the prospectus will not include any untrue statement of a
material fact or omit to state any material fact necessary to make the
statements therein, in the light of the circumstances under which they were
made, not misleading;
(h) otherwise use its commercially reasonable efforts to comply in all
material respects with all applicable rules and regulations of the SEC which
could affect the sale of the Registrable Securities;
(i) use its commercially reasonable efforts to cause all Registrable
Securities to be listed on each securities exchange, if any, on which Common
Stock issued by the Company is then listed;
20
(j) use its commercially reasonable efforts to take all other steps
necessary to effect the registration of the Registrable Securities contemplated
hereby and to enable the Holders to sell Registrable Securities under Rule 144;
(k) the Company shall, at the time the Shelf Registration Statement is
declared effective, cause each Holder that has delivered a properly completed
Questionnaire to the Company on or prior to the later of the date hereof or ten
(10) Business Days prior to the time of effectiveness of the Registration
Statement to be named as a selling securityholder in the Registration Statement
and the related prospectus at the time of effectiveness; and from and after the
date the Registration Statement is declared effective the Company shall, upon
the later of (x) fifteen (15) Business Days after the date a Questionnaire is
delivered or (y) fifteen (15) Business Days after the expiration of any
Suspension Period in effect when the Questionnaire is delivered, if required by
applicable law, file with the SEC a post-effective amendment to the Registration
Statement or prepare and file a supplement to the related prospectus or a
supplement or amendment to any document incorporated therein by reference or
file any other required document so that the Holder delivering such
Questionnaire is named as a selling securityholder in the Registration Statement
and the related prospectus and, if the Company shall file a post-effective
amendment to the Registration Statement, use its commercially reasonable efforts
to cause such post-effective amendment to be declared effective under the
Securities Act as promptly as is practicable; and
(l) to the extent that the final prospectus is not included in the
Registration Statement filed with the SEC, by 9:30 am Eastern time on the
Business Day following the effective date of the Registration Statement, the
Company shall file with the SEC in accordance with Rule 424 under the Securities
Act the final prospectus to be used in connection with sales pursuant to such
Registration Statement.
Section 6.5 Certain Limitations. The Holders shall have no right to
take any action to restrain, enjoin or otherwise delay any registration pursuant
to Section 6.1 hereof as a result of any controversy that may arise with respect
to the interpretation or implementation of this Agreement.
Section 6.6 Indemnity. (a) To the extent permitted by law, the Company
shall indemnify each Holder, its directors, officers, employees and agents
(including each such person who may deemed to be an underwriter under the
Securities Act) and each person controlling such Holder or deemed underwriter
within the meaning of Section 15 of the Securities Act, with respect to which
any registration that has been effected pursuant to this Agreement, against all
claims, losses, damages and liabilities (or action in respect thereof),
including any of the foregoing incurred in settlement of any litigation,
commenced or threatened (subject to Section 6.6(c) below), arising out of or
based on any untrue statement (or alleged untrue statement) of a material fact
contained in the Registration Statement, prospectus, any amendment or supplement
thereof, or issuer free-writing prospectus or based on any omission (or alleged
omission) to state therein a material fact required to be stated therein or
necessary to make the statements therein not misleading, in light of the
circumstances in which they were made, or any violation by the Company of any
rule or regulation promulgated by the Securities Act applicable to the Company
and relating to any action or inaction required of the Company in connection
with any such registration, qualification or compliance, and will reimburse each
21
Holder and deemed underwriter and each person controlling such Holder or deemed
underwriter, for reasonable legal and other out-of-pocket expenses reasonably
incurred in connection with investigating or defending any such claim, loss,
damage, liability or action as incurred; provided that the Company will not be
liable in any such case to the extent that any untrue statement or omission or
allegation thereof is made in reliance upon and in conformity with written
information furnished to the Company by or on behalf of such Holder or deemed
underwriter specifically for use in preparation of such Registration Statement,
prospectus, amendment or supplement, or issuer free-writing prospectus; provided
further that the Company will not be liable in any such case where the claim,
loss, damage or liability arises out of or is related to the failure of such
Holder or deemed underwriter to comply with the covenants and agreements
contained in this Agreement respecting sales of Registrable Securities.
(b) Each Holder will severally, and not jointly, indemnify the
Company, each of its directors, officers, employees and agents, and each person
who controls the Company within the meaning of Section 15 of the Securities Act,
against all claims, losses, damages and liabilities (or actions in respect
thereof), including any of the foregoing incurred in settlement of any
litigation, commenced or threatened (subject to Section 6.6(c) below), arising
out of or based on any untrue statement (or alleged untrue statement) of a
material fact contained in the Registration Statement, prospectus, or any
amendment or supplement thereof, or any other document incident to any such
registration (including any issuer free-writing prospectus), or based on any
omission (or alleged omission) to state therein a material fact required to be
stated therein or necessary to make the statements therein not misleading, in
light of the circumstances in which they were made, and will reimburse the
Company, such directors and officers, and each person controlling the Company
for reasonable legal and any other expenses reasonably incurred in connection
with investigating or defending any such claim, loss, damage, liability or
action as incurred, in each case to the extent, but only to the extent, that
such untrue statement or omission or allegation thereof is made in reliance upon
and in conformity with written information furnished to the Company by or on
behalf of the Holder specifically for use in preparation of the Registration
Statement, prospectus, amendment or supplement, or issuer free-writing
prospectus. Notwithstanding the foregoing, a Holder's aggregate liability
pursuant to this subsection (b) shall be limited to the net amount received by
the Holder from the sale of the Registrable Securities giving rise to such
claims, losses, damages and liabilities (and actions in respect thereof).
(c) Each party entitled to indemnification under this Section 6.6 (the
"Indemnified Party") shall give notice to the party required to provide
indemnification (the "Indemnifying Party") promptly after such Indemnified Party
has actual knowledge of any claim as to which indemnity may be sought, and shall
permit the Indemnifying Party (at its expense) to assume the defense of any such
claim or any litigation resulting therefrom; provided that counsel for the
Indemnifying Party, who shall conduct the defense of such claim or litigation,
shall be approved by the Indemnified Party (whose approval shall not
unreasonably be withheld, conditioned or delayed), and the Indemnified Party may
participate in such defense at such Indemnified Party's expense; provided
further that the failure of any Indemnified Party to give notice as provided
herein shall not relieve the Indemnifying Party of its obligations under this
Agreement, unless such failure is materially prejudicial to the Indemnifying
Party in defending such claim or litigation. An Indemnifying Party shall not be
liable for any settlement of an action or claim effected without its written
consent (which consent will not be unreasonably withheld, conditioned or
delayed). No Indemnifying Party, in its defense of any such claim or
22
litigation, shall, except with the consent (such consent not to be unreasonably
withheld, conditioned or delayed) of the Indemnified Party consent to entry of
any judgment or enter into any settlement which does not include as an
unconditional term thereof the giving by the claimant or plaintiff to such
Indemnified Party of a release from all liability in respect to such claim or
litigation. After notice by the Indemnifying Person to such Indemnified Person
of the Indemnifying Person's election to assume the defense of any claim or
litigation, the Indemnifying Person shall not be liable to such Indemnified
Person for any legal expenses subsequently incurred by such Indemnified Person
in connection with the defense thereof.
(d) If the indemnification provided for in this Section 6.6 is held by
a court of competent jurisdiction to be unavailable to an Indemnified Party or
is insufficient to hold such Indemnified Party harmless with respect to any
loss, liability, claim, damage or expense referred to therein, then the
Indemnifying Party shall contribute to the amount paid or payable by such
Indemnified Party as a result of such loss, liability, claim, damage or expense
in such proportion as is appropriate to reflect the relative fault of the
Indemnifying Party on the one hand and of the Indemnified Party on the other in
connection with the statements or omissions which resulted in such loss,
liability, claim, damage or expense as well as any other relevant equitable
considerations; provided, however, that no Person involved in the sale of
Registrable Securities which Person is guilty of fraudulent misrepresentation
(within the meaning of Section 11(f) of the Securities Act) in connection with
such sale shall be entitled to contribution from any Person involved in such
sale of Registrable Securities as who was not guilty of fraudulent
misrepresentation. The relative fault of the Indemnifying Party and of the
Indemnified Party shall be determined by reference to, among other things,
whether the untrue or alleged untrue statement of a material fact or the
omission to state a material fact relates to information supplied by the
Indemnifying Party or by the Indemnified Party and the parties' relative intent,
knowledge, access to information and opportunity to correct or prevent such
statement or omission. Notwithstanding the foregoing, a Holder's aggregate
liability pursuant to this subsection (d) shall be limited to the net amount
received by the Holder from the sale of Registrable Securities giving rise to
such loss, liability, claim, damage or expense (or actions in respect thereof)
less all other amounts paid as damages in respect thereto.
Section 6.7 Additional Covenants and Agreements of the Holders. (a)
Each Holder agrees that, upon receipt of any notice from the Company of the
happening of any event requiring the preparation of a supplement or amendment to
a prospectus relating to Registrable Securities so that, as thereafter delivered
to the Holders, such prospectus shall not contain an untrue statement of a
material fact or omit to state any material fact required to be stated therein
or necessary to make the statements therein not misleading, each Holder will
forthwith discontinue disposition of Registrable Securities pursuant to the
Registration Statement and prospectus contemplated by Section 6.1 until its
receipt of notice from the Company that the supplemented or amended prospectus
has been filed with the SEC or receipt of copies of the supplemented or amended
prospectus from the Company and, if so directed by the Company, each Holder
shall deliver to the Company all copies, other than permanent file copies then
in such Holder's possession, of the prospectus covering such Registrable
Securities current at the time of receipt of such notice.
(b) Each Holder shall suspend, upon request of the Company, any
disposition of Registrable Securities pursuant to the Registration Statement and
prospectus contemplated by
23
Section 6.1 for a period not to exceed 30 consecutive days (each such period, a
"Suspension Period") to the extent that the Company determines in good faith
that the sale of Registrable Securities under the Registration Statement would
be reasonably likely to cause a violation of the Securities Act or Exchange Act
or would require disclosure of any material pending acquisition or other
corporate transaction and such disclosure would adversely affect the Company;
provided, however, that Suspension Periods shall not exceed an aggregate of 60
days in any 360-day period. The Company shall not be required to specify in the
written notice to the Holders the nature of the event giving rise to the
Suspension Period. Holders hereby agree to hold in confidence any communications
in response to a notice of, or the existence of any fact or any event giving
rise to, the Suspension Period.
(c) As a condition to the inclusion of its Registrable Securities,
each Holder shall furnish to the Company such information regarding such Holder
and the distribution proposed by such Holder as the Company may reasonably
request in writing, including completing a Registration Statement questionnaire
in the form provided by the Company ("Questionnaire"), or as shall be required
in connection with any registration referred to in this Article VI.
(d) Each Holder hereby covenants with the Company (i) not to make any
sale of the Registrable Securities without effectively causing the prospectus
delivery requirements under the Securities Act, if any, to be satisfied, (ii)
not to make any sale of the Registrable Securities to an underwriter or
underwriters for reoffering to the public pursuant to the Registration Statement
and (iii) if such Registrable Securities are to be sold by any method or in any
transaction other than on a national securities exchange or in the
over-the-counter market, in privately negotiated transactions, or in a
combination of such methods, to notify the Company at least five Business Days
prior to the date on which the Holder first offers to sell any such Registrable
Securities.
(e) Each Holder agrees not to take any action with respect to any
distribution deemed to be made pursuant to such Registration Statement which
would constitute a violation of Regulation M under the Exchange Act or any other
applicable rule, regulation or law.
(f) At the end of the Registration Period, the Holders shall
discontinue sales of shares pursuant to such Registration Statement upon receipt
of notice from the Company of its removal from registration of the Registrable
Securities covered by such Registration Statement which remain unsold.
(g) Each Holder represents and agrees that, unless it obtains the
prior consent of the Company, it will not make any offer relating to the
Registrable Securities that would constitute an "issuer free writing
prospectus," as defined in Rule 433, or that would otherwise constitute a "free
writing prospectus," as defined in Rule 405.
Section 6.8 Additional Covenants and Agreements of the Company. With a
view to making available to the Holders the benefits of certain rules and
regulations of the SEC which at any time permit the sale of the Registrable
Securities to the public without registration, so long as the Holders still own
Registrable Securities that may not then be resold pursuant to Rule 144(k), the
Company shall use its reasonable best efforts to:
24
(a) make and keep public information available, as those terms are
understood and defined in Rule 144 under the Securities Act, at all times;
(b) file with the SEC in a timely manner all reports and other
documents required of the Company under the Exchange Act (at any time that it is
subject to such reporting requirements); and
(c) so long as a Holder owns any Registrable Securities, furnish to
such Holder, upon any reasonable request, a written statement by the Company as
to its compliance with Rule 144 under the Securities Act, and of the Exchange
Act, a copy of the most recent annual or quarterly report of the Company, and
such other reports and documents of the Company as such Holder may reasonably
request in availing itself of any rule or regulation of the SEC allowing a
Holder to sell any such securities without registration.
Section 6.9 Assignment of Registration Rights. The rights to cause the
Company to register Registrable Securities granted to the Holders by the Company
under Section 6.1 may be assigned by a Holder in connection with a transfer by
such Holder of all or a portion of its Registrable Securities, provided,
however, that (i) such transfer complies with all applicable securities laws;
(ii) such Holder gives prior written notice to the Company; and (iii) such
transferee agrees in writing to comply with the terms and provisions of this
Agreement, and has provided the Company with a completed Registration Statement
questionnaire in such form as is reasonably requested by the Company. Except as
specifically permitted by this Section 6.9, the rights of a Holder with respect
to Registrable Securities as set out herein shall not be transferable to any
other Person, and any attempted transfer shall cause all rights of such Holder
therein to be forfeited.
Section 6.10 Waiver of Registration Rights. The rights of any Holder
under any provision of this Article VI may be waived (either generally or in a
particular instance, either retroactively or prospectively and either for a
specified period of time or indefinitely) or amended by an instrument in writing
signed by Holders holding not less than a majority of the Registrable
Securities; provided, however, that no consideration shall be offered or paid to
any person to amend or consent to a waiver or modification of any provision of
this Section 6 unless the same consideration also is offered to all Holders of
Registrable Securities.
ARTICLE VII
DEFINITIONS
-----------
Section 7.1 Definitions. The following capitalized terms have the
following meanings:
"Affiliate" means, with respect to any Person (as defined below), any
other Person controlling, controlled by or under direct or indirect common
control with such Person (for the purposes of this definition "control," when
used with respect to any specified Person, shall mean the power to direct the
management and policies of such person, directly or indirectly, whether through
ownership of voting securities, by contract or otherwise; and the terms
"controlling" and "controlled" shall have meanings correlative to the
foregoing).
25
"Business Day" means a day Monday through Friday on which banks are
generally open for business in New York City.
"Closing" has the meaning set forth in Section 1.3.
"Closing Date" has the meaning set forth in Section 1.3. "Common
Stock" has the meaning set forth in the introduction.
"Company" has the meaning set forth in the preamble.
"Exchange Act" means the Securities Exchange Act of 1934, as amended,
and the rules and regulations thereunder, or any successor statute.
"Filing Date" has the meaning set forth in Section 6.1.
"Final Prospectus" has the meaning set forth in Section 6.6(a).
"Financial Statements" means the financial statements of the Company
included in the SEC Documents.
"Holder" means any Purchaser holding Registrable Securities or any
person to whom the rights under Article VI have been transferred in accordance
with Section 6.9 hereof.
"Indemnified Party" has the meaning set forth in Section 6.6(c).
"Indemnifying Party" has the meaning set forth in Section 6.6(c).
"Intellectual Property" has the meaning set forth in Section 2.8.
"Knowledge of the Company" means the actual knowledge of the
executive officers of the Company, after reasonable inquiry.
"Material Adverse Effect" means a material adverse effect on (a) the
business, operations, assets or financial condition of the Company and its
subsidiaries, taken as a whole, or (b) the ability of the Company to perform its
obligations pursuant to the transactions contemplated by this Agreement.
"Material Agreements" has the meaning set forth in Section 2.6.
"Material Subsidiary" means a "significant subsidiary" as defined in
Rule 1-02 of Regulation S-X.
"Nasdaq" means The Nasdaq Global Select Market.
"Offering" means the private placement of the Company's Shares
contemplated by this Agreement.
"Penalty Period" has the meaning set forth in Section 6.3.
26
"Person" means any person, individual, corporation, limited liability
company, partnership, trust or other nongovernmental entity or any governmental
agency, court, authority or other body (whether foreign, federal, state, local
or otherwise).
"Placement Agent" means Banc of America Securities LLC.
"Purchasers" mean the Purchasers whose names are set forth on the
signature pages of this Agreement, and their permitted transferees.
"Purchase Price" has the meaning set forth in Section 1.1.
"register," "registered" and "registration" refer to the registration
effected by preparing and filing a registration statement in compliance with the
Securities Act, and the declaration or ordering of the effectiveness of such
registration statement.
"Registrable Securities" means the Shares (including any shares of
Common Stock issued in connection with any stock dividend on or any split or
subdivision of the Shares); provided, however, that securities shall only be
treated as Registrable Securities if and only for so long as they (A) have not
been disposed of pursuant to a registration statement declared effective by the
SEC, (B) have not been sold in a transaction exempt from the registration and
prospectus delivery requirements of the Securities Act and (C) are held by a
Holder or a permitted transferee pursuant to Section 6.9.
"Registration Default" has the meaning set forth in Section 6.3.
"Registration Expenses" means all expenses incurred by the Company in
complying with Section 6.1 hereof, including, without limitation, all
registration, qualification and filing fees, printing expenses, escrow fees,
fees and expenses of counsel for the Company, blue sky fees and expenses and the
expense of any special audits incident to or required by any such registration
(but excluding the Selling Expenses of any Holder).
"Registration Period" has the meaning set forth in Section 6.4(a).
"Registration Statement" has the meaning set forth in Section 6.1.
"Rule 144" means Rule 144 promulgated under the Securities Act, or
any successor rule.
"SEC" means the United States Securities and Exchange Commission.
"SEC Documents" has the meaning set forth in Section 2.6.
"Securities Act" means the Securities Act of 1933, as amended, and
the rules and regulations thereunder, or any similar successor statute.
"Selling Expenses" means all selling commissions and stock transfer
taxes applicable to the sale of Registrable Securities and all fees and expenses
of legal counsel for any Holder.
27
"Shares" has the meaning set forth in Section 1.1.
"Suspension Period" has the meaning set forth in Section 6.7(b).
Section 7.2 Certain Interpretations. Except where expressly stated
otherwise in this Agreement, the following rules of interpretation apply to this
Agreement: (i) "or" is not exclusive and "include", "includes" and "including"
are not limiting; (ii) definitions contained in this Agreement are applicable to
the singular as well as the plural forms of such terms; (iii) references to an
agreement or instrument mean such agreement or instrument as from time to time
amended, modified or supplemented; (iv) references to a Person are also to its
permitted successors and assigns; (v) references to an "Article", "Section",
"Subsection", "Exhibit" or "Schedule" refer to an Article of, a Section or
Subsection of, or an Exhibit or Schedule to, this Agreement; and (vi) words
importing the masculine gender include the feminine or neuter and, in each case,
vice versa.
ARTICLE VIII
GOVERNING LAW; MISCELLANEOUS
----------------------------
Section 8.1 Governing Law; Jurisdiction; Waiver of Jury Trial. This
Agreement will be governed by and interpreted in accordance with the laws of the
State of New York without giving effect to any choice of law or conflict of law
provision or rule (whether of the State of New York or any other jurisdiction)
that would cause the application of the laws of any jurisdictions other than the
State of New York. Each of the parties hereto irrevocably submits and consents
to the exclusive jurisdiction of the courts of the State of New York and the
United States District Court for the Southern District of New York, in each case
located in the Borough of Manhattan, for the purpose of any suit, action,
proceeding or judgment relating to or arising out of this Agreement and the
transactions contemplated hereby. Each party hereto irrevocably waives any
objection to the laying of venue of any such suit, action or proceeding brought
in such courts and irrevocably waives any claim that any such suit, action or
proceeding brought in any such court has been brought in an inconvenient forum.
EACH OF THE PARTIES HERETO WAIVES ANY RIGHT TO REQUEST A TRIAL BY JURY IN ANY
LITIGATION WITH RESPECT TO THIS AGREEMENT AND REPRESENTS THAT COUNSEL HAS BEEN
CONSULTED SPECIFICALLY AS TO THIS WAIVER.
Section 8.2 Counterparts; Signatures by Facsimile. This Agreement may
be executed in two or more counterparts, all of which are considered one and the
same agreement and will become effective when counterparts have been signed by
each party and delivered to the other parties. This Agreement, once executed by
a party, may be delivered to the other parties hereto by facsimile transmission
of a copy of this Agreement bearing the signature of the party so delivering
this Agreement.
Section 8.3 Headings. The headings of this Agreement are for
convenience of reference only, are not part of this Agreement and do not affect
its interpretation.
Section 8.4 Severability. If any provision of this Agreement is
invalid or unenforceable under any applicable statute or rule of law, then such
provision will be deemed modified in order to conform with such statute or rule
of law. Any provision hereof that may
28
prove invalid or unenforceable under any law will not affect the validity or
enforceability of any other provision hereof.
Section 8.5 Entire Agreement; Amendments. This Agreement (including
all schedules and exhibits hereto) and any confidentiality agreement entered
into between the Company and a Purchaser solely with respect to such Purchaser
(which confidentiality agreement shall continue to be in full force and effect)
constitutes the entire agreement among the parties hereto with respect to the
subject matter hereof and thereof. There are no restrictions, promises,
warranties or undertakings, other than those set forth or referred to herein or
therein. This Agreement supersedes all prior agreements and understandings among
the parties hereto with respect to the subject matter hereof. No provision of
this Agreement may be waived or amended other than by an instrument in writing
signed by the party to be charged with enforcement. Any amendment or waiver
effected in accordance with this Section 8.5 shall be binding upon each holder
of any Shares purchased under this Agreement at the time outstanding, each
future holder of all such securities, and the Company.
Section 8.6 Notices. All notices required or permitted hereunder shall
be in writing and shall be deemed effectively given: (a) upon personal delivery
to the party to be notified, (b) when sent by confirmed email, telex or
facsimile if sent during normal business hours of the recipient, if not, then on
the next business day, (c) five days after having been sent by registered or
certified mail, return receipt requested, postage prepaid, or (d) one business
day after deposit with a nationally recognized overnight courier, specifying
next day delivery, with written verification of receipt. The addresses for such
communications are:
If to the Company: Euronet Worldwide, Inc.
0000 Xxxxxxx Xxxxxxxxx
Xxxxx 000
Xxxxxxx, Xxxxxx 00000
Facsimile: (000) 000-0000
Attn: Legal Department
With a copy to: Xxxxxxx Xxxxxxxx Xxxxxx, LLP
0000 Xxxxxx
Xxxxx 0000
Xxxxxx Xxxx, XX 00000
Attn: Xxxx X. Xxxxxx
Xxxxx X. Xxxxxxx
If to a Purchaser: To the address set forth immediately below on
Exhibit A hereto. Each party will provide ten days' advance written notice to
the other parties of any change in its address.
Section 8.7 Successors and Assigns. This Agreement is binding upon and
inures to the benefit of the parties and their successors and assigns. The
Company will not assign this Agreement or any rights or obligations hereunder
without the prior written consent of the Purchasers, and no Purchaser may assign
this Agreement or any rights or obligations
29
hereunder without the prior written consent of the Company, except as permitted
in accordance with Section 6.9 hereof.
Section 8.8 Third Party Beneficiaries. This Agreement is intended for
the benefit of the parties hereto, their respective permitted successors and
assigns and the Placement Agent, and is not for the benefit of, nor may any
provision hereof be enforced by, any other person, except as provided in Section
6.6.
Section 8.9 Further Assurances. Each party will do and perform, or
cause to be done and performed, all such further acts and things, and will
execute and deliver all other agreements, certificates, instruments and
documents, as another party may reasonably request in order to carry out the
intent and accomplish the purposes of this Agreement and the consummation of the
transactions contemplated hereby.
Section 8.10 No Strict Construction. The language used in this
Agreement is deemed to be the language chosen by the parties to express their
mutual intent, and no rules of strict construction will be applied against any
party.
Section 8.11 Equitable Relief. Each Purchaser and each holder of the
Shares shall have all rights and remedies set forth in this Agreement and all
rights and remedies which such holders have been granted at any time under any
other agreement or contract and all of the rights which such holders have under
any law. Any Person having any rights under any provision of this Agreement
shall be entitled to enforce such rights specifically (without posting a bond or
other security), to recover damages by reason of any breach of any provision of
this Agreement and to exercise all other rights granted by law. The Company
recognizes that if it fails to perform or discharge any of its obligations under
this Agreement, any remedy at law may prove to be inadequate relief to the
Purchasers. The Company therefore agrees that the Purchasers are entitled to
seek temporary and permanent injunctive relief in any such case without the
necessity of proving actual damages and without posting a bond or other
security. Each Purchaser also recognizes that, if it fails to perform or
discharge any of its obligations under this Agreement, any remedy at law may
prove to be inadequate relief to the Company. Each Purchaser therefore agrees
that the Company is entitled to seek temporary and permanent injunctive relief
in any such case without the necessity of proving actual damages and without
posting a bond or other security.
Section 8.12 Survival of Representations and Warranties.
Notwithstanding any investigation made by any party to this Agreement, all
representations and warranties made by the Company and the Purchasers herein
shall survive for a period of two years following the date hereof.
Section 8.13 Independent Nature of Purchasers' Obligations and Rights.
The obligations of each Purchaser under this Agreement are several and not joint
with the obligations of any other Purchaser, and no Purchaser shall be
responsible in any way for the representations and warranties of, or the
performance of the obligations of any other Purchaser under this Agreement.
Nothing contained herein and no action taken by any Purchaser pursuant thereto,
shall be deemed to constitute the Purchasers as a partnership, an association, a
joint venture or any other kind of entity, or create a presumption that the
Purchasers are in any way
30
acting in concert or as a group, or are deemed affiliates (as such term is
defined under the Exchange Act) with respect to such obligations or the
transactions contemplated by this Agreement. Each Purchaser shall be entitled to
independently protect and enforce its rights, including without limitation the
rights arising out of this Agreement, and it shall not be necessary for any
other Purchaser to be joined as an additional party in any proceeding for such
purpose.
Section 8.14 Termination. Without limiting the remedies of the parties
hereunder, in the event that the Closing shall not have occurred with respect to
a Purchaser on or before five (5) Business Days from and after the date hereof,
either the Company or such Purchaser shall have the option to terminate this
Agreement, provided that the right to terminate this Agreement shall not be
available to (a) the Company if its failure to fulfill any obligation under this
Agreement has been the cause of, or resulted in, the failure of the Closing to
occur on or before such date or (b) such Purchaser if the failure of such
Purchaser to fulfill any obligation under this Agreement has been the cause of,
or resulted in, the failure of the Closing to occur.
[Signature Page Follows]
31
IN WITNESS WHEREOF, the undersigned Purchasers and the Company have
caused this Agreement to be duly executed as of the date first above written.
EURONET WORLDWIDE, INC.
By: /s/ Xxxx Xxxxxx
-------------------------
Name: Xxxx Xxxxxx
Title: Chief Financial Officer
SECURITIES PURCHASE AGREEMENT
SIGNATURE PAGE
PURCHASER
S.A.C. Capital Associates, LLC
By: S.A.C. Capital Advisors, LLC,
Authorized Signatory
By: /s/ Xxxxx X. Xxxxxxxx
---------------------------------
Name: Xxxxx X. Xxxxxxxx
Title: General Counsel
Address:
FOR PURPOSES OF RESIDENCE AND PRINCIPAL
PLACE OF BUSINESS:
X.X. Xxx 00
Xxxxxxxx Xxxxx
Xxx Xxxxxx
Xxxxxxxx, BWI
FOR PURPOSES OF MAILINGS OF
CORRESPONDENCE AND CERTIFICATES:
c/o S.A.C. Capital Advisors, LLC
00 Xxxxxxxx Xxxxx Xxxx
Xxxxxxxx, Xxxxxxxxxxx 00000
Attn: General Counsel
Facsimile: 000-000-0000
SECURITIES PURCHASE AGREEMENT
SIGNATURE PAGE
PURCHASER
Radcliffe SPC, Ltd. for and on behalf of
the Class A Segregated Portfolio
By: RG Capital Management, L.P.
By: RGC Management Company, LLC
By: /s/ Xxxxxx X. Xxxxxxxxxx
---------------------------------------
(signature)
Xxxxxx X. Xxxxxxxxxx, Managing Director
---------------------------------------
(print name and title)
Address: c/o RG Capital Management, L.P.
0 Xxxx Xxxxx - Xxxx, Xxxxx 000
Xxxx Xxxxxx, XX 00000
Facsimile: (000) 000-0000
SECURITIES PURCHASE AGREEMENT
SIGNATURE PAGE
PURCHASER
Xxxxxx Bay Fund LP
------------------------------
(investor name)
By: /s/ Xxxxxx Xxxxxx
-------------------------------
(signature)
Xxxxxx Xxxxxx, Principal
------------------------------
(print name and title)
Address: 000 Xxxxxxxx, 00xx Xxxxx
Xxx Xxxx, XX 00000
Facsimile: 000-000-0000
SECURITIES PURCHASE AGREEMENT
SIGNATURE PAGE
PURCHASER
Xxxxxx Bay Overseas Fund LTD
------------------------------
(investor name)
By: /s/ Xxxxxx Xxxxxx
(signature)
Xxxxxx Xxxxxx, Principal
------------------------------
(print name and title)
Address: 000 Xxxxxxxx, 00xx Xxxxx
Xxx Xxxx, XX 00000
Facsimile: 000-000-0000
SECURITIES PURCHASE AGREEMENT
SIGNATURE PAGE
PURCHASER
AIM EQUITY FUNDS ON BEHALF OF ITS SERIES
PORTFOLIO AIM CAPITAL DEVELOPMENT FUND
AIM FUNDS GROUP ON BEHALF OF ITS SERIES
PORTFOLIO AIM SMALL CAP EQUITY FUND
AIM VARIABLE INSURANCE FUNDS ON BEHALF OF ITS
SERIES PORTFOLIOS AIM V.I. CAPITAL DEVELOPMENT
FUND AND AIM V.I. SMALL CAP EQUITY FUND
(investor name)
By: /s/ Xxxx X. Xxxx
-----------------------------------
Xxxx X. Xxxx, Senior Vice President
Address: A I M ADVISORS, INC.
00 Xxxxxxxx Xxxxx, Xxxxx 000
Xxxxxxx, Xxxxx 00000-0000
Facsimile: 713.993.9185
SECURITIES PURCHASE AGREEMENT
SIGNATURE PAGE
PURCHASER
SMALLCAP World Fund, Inc.,
by Capital Research and Management Company,
its investment advisor
(investor name)
By: /s/ Xxxxxxx Xxxxxx
-------------------------------------
(signature)
Xxxxxxx Xxxxxx, Senior Vice President
and the Secretary
-------------------------------------
(print name and title)
Address: c/o Capital Research and Management
Company
000 Xxxxx Xxxx Xxxxxx
Xxx Xxxxxxx, XX 00000
Facsimile: 000-000-0000
SECURITIES PURCHASE AGREEMENT
SIGNATURE PAGE
PURCHASER
New World Fund,
by Capital Research and Management Company,
its investment adviser
(investor name)
By: /s/ Xxxxxxx Xxxxxx
-------------------------------------
(signature)
Xxxxxxx Xxxxxx, Senior Vice President
and the Secretary
-------------------------------------
(print name and title)
Address: c/o Capital Research and Management
Company
000 Xxxxx Xxxx Xxxxxx
Xxx Xxxxxxx, XX 00000
Facsimile: 000-000-0000
SECURITIES PURCHASE AGREEMENT
SIGNATURE PAGE
PURCHASER
American Funds Insurance Series - New World
Fund, by Capital Research and Management
Company, its investment adviser
(investor name)
By: /s/ Xxxxxxx Xxxxxx
-------------------------------------
(signature)
Xxxxxxx Xxxxxx, Senior Vice President
and the Secretary
-------------------------------------
(print name and title)
Address: c/o Capital Research and Management
Company
000 Xxxxx Xxxx Xxxxxx
Xxx Xxxxxxx, XX 00000
Facsimile: 000-000-0000
SECURITIES PURCHASE AGREEMENT
SIGNATURE PAGE
PURCHASER
UBS X'Xxxxxx LLC fbo X'Xxxxxx PIPES Corporate
Strategies Master Limited
(investor name)
By: /s/ Xxxx Xxxxxx
---------------------------
(signature)
Xxxx Xxxxxx (Executive Director)
--------------------------------
(print name and title)
Address: Xxx Xxxxx Xxxxxx Xxxxx
Xxxxxxx, XX 00000
Facsimile: 000-000-0000
SECURITIES PURCHASE AGREEMENT
SIGNATURE PAGE
PURCHASER
UBS X'Xxxxxx LLC fbo X'Xxxxxx Global
Convertible Arbitrage Master Limited
(investor name)
By: /s/ Xxxx Xxxxxxxx
---------------------------
(signature)
Xxxx Xxxxxxxx (Managing Director)
---------------------------------
(print name and title)
Address: Xxx Xxxxx Xxxxxx Xxxxx
Xxxxxxx, XX 00000
Facsimile: 000-000-0000
SECURITIES PURCHASE AGREEMENT
SIGNATURE PAGE
PURCHASER
UBS X'Xxxxxx LLC fbo X'Xxxxxx Global
Convertible Arbitrage II Master Limited
(investor name)
By: /s/ Xxxx Xxxxxxxx
---------------------------
(signature)
Xxxx Xxxxxxxx (Managing Director)
---------------------------------
(print name and title)
Address: Xxx Xxxxx Xxxxxx Xxxxx
Xxxxxxx, XX 00000
Facsimile: 000-000-0000
SECURITIES PURCHASE AGREEMENT
SIGNATURE PAGE
PURCHASER
Silver Oak Capital LLC
(investor name)
By: /s/ Xxxxxx X. Xxxxxxxxxxx
---------------------------------
(signature)
Xxxxxx X. Xxxxxxxxxxx, Manager
------------------------------------------
(print name and title)
Address: 000 Xxxx Xxxxxx
00xx Xxxxx
Xxx Xxxx, XX 00000
Facsimile: 000-000-0000
SECURITIES PURCHASE AGREEMENT
SIGNATURE PAGE
PURCHASER
Portside Growth & Opportunity Fund
(investor name)
By: /s/ Xxxxxxx X. Xxxxx
---------------------------------
(signature)
Xxxxxxx X. Xxxxx, Authorized Signatory
--------------------------------------
(print name and title)
Address: Ramius Capital Group
000 Xxxxx Xxxxxx, 00xx Xxxxx
Xxx Xxxx, XX 00000
Facsimile: (000) 000-0000
SECURITIES PURCHASE AGREEMENT
SIGNATURE PAGE
PURCHASER
Magnetar Capital Master Fund, Ltd.
Magnetar Financial LLC, its investment manager
(investor name)
By: /s/ Xxxx Xxxxx
-----------------------------
(signature)
Xxxx Xxxxx, General Counsel
------------------------------------
(print name and title)
Address: c/o Magnetar Financial LLC
0000 Xxxxxxxxx Xxxxxx, 00xx Xxxxx
Xxxxxxxx, Xxxxxxxx 00000
Facsimile: 000-000-0000
SECURITIES PURCHASE AGREEMENT
SIGNATURE PAGE
PURCHASER
Mac & Co.
(investor name)
By: /s/ Xxxx Xxxxxx
---------------------------
(signature)
Xxxx Xxxxxx, Investment Advisor to Purchaser
--------------------------------------------
(print name and title)
Address: Xxxxxxx Xxxxx & Co.
000 X. Xxxxx Xxxxxx
Xxxxxxx, XX 00000
Attn: Xxxxxxx Xxxxxx
Facsimile: 312.577.0908
SECURITIES PURCHASE AGREEMENT
SIGNATURE PAGE
PURCHASER
Xxxxxxx & Co. FFC City of Dearborn Policemen
and Firemen Revised Retirement Systems
(investor name)
By: /s/ Xxxx Xxxxxx
---------------------------
(signature)
Xxxx Xxxxxx, Investment Advisor to Purchaser
--------------------------------------------
(print name and title)
Address: Xxxxxxx Xxxxx & Co.
000 X. Xxxxx Xxxxxx
Xxxxxxx, XX 00000
Attn: Xxxxxxx Xxxxxx
Facsimile: 312.577.0908
SECURITIES PURCHASE AGREEMENT
SIGNATURE PAGE
PURCHASER
Xxxxxxx & Co. FFC City of Dearborn General
Employees Retirement System
(investor name)
By: /s/ Xxxx Xxxxxx
---------------------------
(signature)
Xxxx Xxxxxx, Investment Advisor to Purchaser
--------------------------------------------
(print name and title)
Address: Xxxxxxx Xxxxx & Co.
000 X. Xxxxx Xxxxxx
Xxxxxxx, XX 00000
Attn: Xxxxxxx Xxxxxx
Facsimile: 312.577.0908
SECURITIES PURCHASE AGREEMENT
SIGNATURE PAGE
PURCHASER
Xxxxxxx Xxxxx Small Cap Growth Fund
(investor name)
By: /s/ Xxxx Xxxxxx
---------------------------
(signature)
Xxxx Xxxxxx, Investment Advisor to Purchaser
--------------------------------------------
(print name and title)
Address: Xxxxxxx Xxxxx & Co.
000 X. Xxxxx Xxxxxx
Xxxxxxx, XX 00000
Attn: Xxxxxxx Xxxxxx
Facsimile: 312.577.0908
SECURITIES PURCHASE AGREEMENT
SIGNATURE PAGE
PURCHASER
Booth & Co. FFC Hartmarx Retirement
Income Trust
(investor name)
By: /s/ Xxxx Xxxxxx
---------------------------
(signature)
Xxxx Xxxxxx, Investment Advisor to Purchaser
--------------------------------------------
(print name and title)
Address: Xxxxxxx Xxxxx & Co.
000 X. Xxxxx Xxxxxx
Xxxxxxx, XX 00000
Attn: Xxxxxxx Xxxxxx
Facsimile: 312.577.0908
SECURITIES PURCHASE AGREEMENT
SIGNATURE PAGE
PURCHASER
Booth & Co. FFC Rush University Medical Center
Endowment Account
(investor name)
By: /s/ Xxxx Xxxxxx
---------------------------
(signature)
Xxxx Xxxxxx, Investment Advisor to Purchaser
--------------------------------------------
(print name and title)
Address: Xxxxxxx Xxxxx & Co.
000 X. Xxxxx Xxxxxx
Xxxxxxx, XX 00000
Attn: Xxxxxxx Xxxxxx
Facsimile: 312.577.0908
SECURITIES PURCHASE AGREEMENT
SIGNATURE PAGE
PURCHASER
Booth & Co. FFC Rush University Medical Center
Pension & Retirement
(investor name)
By: /s/ Xxxx Xxxxxx
---------------------------
(signature)
Xxxx Xxxxxx, Investment Advisor to Purchaser
--------------------------------------------
(print name and title)
Address: Xxxxxxx Xxxxx & Co.
000 X. Xxxxx Xxxxxx
Xxxxxxx, XX 00000
Attn: Xxxxxxx Xxxxxx
Facsimile: 312.577.0908
SECURITIES PURCHASE AGREEMENT
SIGNATURE PAGE
PURCHASER
Capital Ventures International
by Heights Capital Management, Inc.
its authorized agent
(investor name)
By: /s/ Xxxxxxx Xxxxxx
---------------------------------
(signature)
Xxxxxxx Xxxxxx, Counsel
------------------------------
(print name and title)
Address: c/o Heights Capital Management
000 Xxxxxxxxxx Xxxxxx, Xxxxx 0000
Xxx Xxxxxxxxx, XX 00000
Facsimile: 000-000-0000
SECURITIES PURCHASE AGREEMENT
SIGNATURE PAGE
PURCHASER
Enable Growth Partners LP
(investor name)
By: /s/ Xxxxxxx X'Xxxx
---------------------------------
(signature)
Xxxxxxx X'Xxxx, Principal and Portfolio Manager
-----------------------------------------------
(print name and title)
Address: Xxx Xxxxx Xxxxxxxx, Xxxxx 000
Xxx Xxxxxxxxx, XX 00000
Facsimile: 000-000-0000
Aggregated Purchase Price: $8,500,000.00
Number of Shares: 340,000
SECURITIES PURCHASE AGREEMENT
SIGNATURE PAGE
PURCHASER
Xxxxxx Diversified Strategy Master Fund LLC, Ena
(investor name)
By: /s/ Xxxxxxx X'Xxxx
---------------------------------
(signature)
Xxxxxxx X'Xxxx, Principal and Portfolio Manager
-----------------------------------------------
(print name and title)
Address: Xxx Xxxxx Xxxxxxxx, Xxxxx 000
Xxx Xxxxxxxxx, XX 00000
Facsimile: 000-000-0000
Aggregated Purchase Price: $500,000.00
Number of Shares: 20,000
SECURITIES PURCHASE AGREEMENT
SIGNATURE PAGE
PURCHASER
Enable Opportunity Partners LP
(investor name)
By: /s/ Xxxxxxx X'Xxxx
---------------------------------
(signature)
Xxxxxxx X'Xxxx, Principal and Portfolio Manager
-----------------------------------------------
(print name and title)
Address: Xxx Xxxxx Xxxxxxxx, Xxxxx 000
Xxx Xxxxxxxxx, XX 00000
Facsimile: 000-000-0000
Aggregated Purchase Price: $1,000,000.00
Number of Shares: 40,000
SECURITIES PURCHASE AGREEMENT
SIGNATURE PAGE
PURCHASER
Highbridge International LLC
By: Highbridge Capital Management, LLC
(investor name)
By: /s/ Xxxx X. Chill
---------------------
(signature)
Xxxx X. Chill, Managing Director
--------------------------------
(print name and title)
Address: c/o Highbridge Capital Management, LLC
0 Xxxx 00xx Xxxxxx, 00xx Xxxxx
Xxx Xxxx, XX 00000
Attn: Xxx X. Starch/Xxxx X. Chill
Facsimile: 212-751-0755
SECURITIES PURCHASE AGREEMENT
SIGNATURE PAGE
PURCHASER
Arkansas Teachers Retirement Systems
Xxxxxxxx Investment Management Group, LLC
By: /s/ Xxxxxxx X. Xxxxx
---------------------------------
Power of Attorney
Xxxxxxx X. Xxxxx, Chief Operating Officer
-----------------------------------------
(print name and title)
Address: 000 Xxxxxx Xxxxxx
Xxxxxx Xxxx, XX 00000
Facsimile: 000-000-0000
SECURITIES PURCHASE AGREEMENT
SIGNATURE PAGE
PURCHASER
Arkansas Public Employees Retirement Systems
Xxxxxxxx Investment Management Group, LLC
By: /s/ Xxxxxxx X. Xxxxx
---------------------------------
Power of Attorney
Xxxxxxx X. Xxxxx, Chief Operating Officer
------------------------------------------
(print name and title)
Address: 000 Xxxxxx Xxxxxx
Xxxxxx Xxxx, XX 00000
Facsimile: 000-000-0000
SECURITIES PURCHASE AGREEMENT
SIGNATURE PAGE
PURCHASER
Baptist Health Springhill
Xxxxxxxx Investment Management Group, LLC
By: /s/ Xxxxxxx X. Xxxxx
---------------------------------
Power of Attorney
Xxxxxxx X. Xxxxx, Chief Operating Officer
------------------------------------------
(print name and title)
Address: 000 Xxxxxx Xxxxxx
Xxxxxx Xxxx, XX 00000
Facsimile: 000-000-0000
SECURITIES PURCHASE AGREEMENT
SIGNATURE PAGE
PURCHASER
Baptist Health HELP
Xxxxxxxx Investment Management Group, LLC
By: /s/ Xxxxxxx X. Xxxxx
---------------------------------
Power of Attorney
Xxxxxxx X. Xxxxx, Chief Operating Officer
------------------------------------------
(print name and title)
Address: 000 Xxxxxx Xxxxxx
Xxxxxx Xxxx, XX 00000
Facsimile: 000-000-0000
SECURITIES PURCHASE AGREEMENT
SIGNATURE PAGE
PURCHASER
Xxxxxxxx Group, Inc.
Xxxxxxxx Investment Management Group, LLC
By: /s/ Xxxxxxx X. Xxxxx
---------------------------------
Power of Attorney
Xxxxxxx X. Xxxxx, Chief Operating Officer
------------------------------------------
(print name and title)
Address: 000 Xxxxxx Xxxxxx
Xxxxxx Xxxx, XX 00000
Facsimile: 000-000-0000
SECURITIES PURCHASE AGREEMENT
SIGNATURE PAGE
PURCHASER
Xxxxxxxx Investment Holdings, LLC
Xxxxxxxx Investment Management Group, LLC
By: /s/ Xxxxxxx X. Xxxxx
---------------------------------
Power of Attorney
Xxxxxxx X. Xxxxx, Chief Operating Officer
------------------------------------------
(print name and title)
Address: 000 Xxxxxx Xxxxxx
Xxxxxx Xxxx, XX 00000
Facsimile: 000-000-0000
SECURITIES PURCHASE AGREEMENT
SIGNATURE PAGE
PURCHASER
Xxxxxxx X. Xxxxxxxx Trust UID March 22, 1984
Xxxxxxxx Investment Management Group, LLC
By: /s/ Xxxxxxx X. Xxxxx
---------------------------------
Power of Attorney
Xxxxxxx X. Xxxxx, Chief Operating Officer
------------------------------------------
(print name and title)
Address: 000 Xxxxxx Xxxxxx
Xxxxxx Xxxx, XX 00000
Facsimile: 000-000-0000
SECURITIES PURCHASE AGREEMENT
SIGNATURE PAGE
PURCHASER
Xxxxxx and Xxxxxxx Xxxxxxxx Children's Trust
UID September 30, 1987 Xxx X.X. Xxxxxx Trustee
Xxxxxxxx Investment Management Group, LLC
By: /s/ Xxxxxxx X. Xxxxx
---------------------------------
Power of Attorney
Xxxxxxx X. Xxxxx, Chief Operating Officer
------------------------------------------
(print name and title)
Address: 000 Xxxxxx Xxxxxx
Xxxxxx Xxxx, XX 00000
Facsimile: 000-000-0000
SECURITIES PURCHASE AGREEMENT
SIGNATURE PAGE
PURCHASER
Stephens Small Cap Fund
Xxxxxxxx Investment Management Group, LLC
By: /s/ Xxxxxxx X. Xxxxx
---------------------------------
Power of Attorney
Xxxxxxx X. Xxxxx, Chief Operating Officer
------------------------------------------
(print name and title)
Address: 000 Xxxxxx Xxxxxx
Xxxxxx Xxxx, XX 00000
Facsimile: 000-000-0000
SECURITIES PURCHASE AGREEMENT
SIGNATURE PAGE
PURCHASER
St. Vincents Foundation
Xxxxxxxx Investment Management Group, LLC
By: /s/ Xxxxxxx X. Xxxxx
---------------------------------
Power of Attorney
Xxxxxxx X. Xxxxx, Chief Operating Officer
------------------------------------------
(print name and title)
Address: 000 Xxxxxx Xxxxxx
Xxxxxx Xxxx, XX 00000
Facsimile: 000-000-0000
SECURITIES PURCHASE AGREEMENT
SIGNATURE PAGE
EXHIBIT A
SCHEDULE OF PURCHASERS
(1) (2) (3) (4) (5)
Aggregate
Number of Legal Representative's
Buyer Address and Facsimile Number Common Shares Purchase Price Address and Facsimile Number
----- ---------------------------- ------------- -------------- ----------------------------
AIM Small Cap Equity Fund, a series A I M Advisors, Inc. 137,788 $ 3,444,700.00
portfolio of AIM Funds Group 00 Xxxxxxxx Xxxxx, Xxxxx 000
Xxxxxxx, XX 00000
Attn: Xxxxxx Xxxxxx and Xxxxx
Xxxxxx
Fax: (000) 000-0000
AIM Capital Development Fund, a A I M Advisors, Inc. 662,000 16,550,000.00
series portfolio of AIM Equity Funds 00 Xxxxxxxx Xxxxx, Xxxxx 000
Xxxxxxx, XX 00000
Attn: Xxxxxx Xxxxxx and Xxxxx
Xxxxxx
Fax: (000) 000-0000
AIM V.I. Small Cap Equity Fund, a A I M Advisors, Inc. 29,040 726,000.00
series portfolio of AIM Variable 00 Xxxxxxxx Xxxxx, Xxxxx 000
Insurance Funds Xxxxxxx, XX 00000
Attn: Xxxxxx Xxxxxx and Xxxxx
Xxxxxx
Fax: (000) 000-0000
AIM V.I. Capital Development Fund, a A I M Advisors, Inc. 113,000 2,825,000.00
series portfolio of AIM Variable 00 Xxxxxxxx Xxxxx, Xxxxx 000
Insurance Funds Xxxxxxx, XX 00000
Attn: Xxxxxx Xxxxxx and Xxxxx
Xxxxxx
Fax: (000) 000-0000
SMALLCAP World Fund, Inc. c/o Capital Research and 200,000 5,000,000.00 Xxxx Xxxxxxx
Management Company 333 So. Hope St.
000 Xxxxx Xxxx Xxxxxx Xxx Xxxxxxx, XX 00000
Xxx Xxxxxxx, XX 00000 Fax: (000) 000-0000
Attn: Xxxxxx X. Xxxxxxx Telephone: (000) 000-0000
Fax: (000) 000-0000
New World Fund, Inc. c/o Capital Research and 1,055,000 26,375,000.00 Xxxx Xxxxxxx
Management Company 333 So. Hope St.
000 Xxxxx Xxxx Xxxxxx Xxx Xxxxxxx, XX 00000
Xxx Xxxxxxx, XX 00000 Fax: (000) 000-0000
Attn: Xxxxxx X. Xxxxxxx Telephone: (000) 000-0000
Fax: (000) 000-0000
American Funds Insurance Series - c/o Capital Research and 250,000 6,250,000.00 Xxxx Xxxxxxx
New World Fund Management Company 333 So. Hope St.
000 Xxxxx Xxxx Xxxxxx Xxx Xxxxxxx, XX 00000
Xxx Xxxxxxx, XX 00000 Fax: (000) 000-0000
Attn: Xxxxxx X. Xxxxxxx Telephone: (000) 000-0000
Fax: (000) 000-0000
UBS X'Xxxxxx LLC fbo X'Xxxxxx PIPES One North Xxxxxx Drive 200,000 5,000,000.00 Xxxxxxx Xxxx & Xxxxx LLP
Corporate Strategies Master Limited Xxxxxxx, XX 00000 000 Xxxxx Xxxxxx
Attn: Xxxxx Xxxxxxx Xxx Xxxx, Xxx Xxxx 00000
Fax: (000) 000-0000 Fax: (000) 000-0000
Telephone: (000) 000-0000
Attn: Xxxxxxx X. Xxxxx, Esq.
A-1
UBS X'Xxxxxx LLC fbo X'Xxxxxx Global One North Xxxxxx Drive 185,000 4,625,000.00 Xxxxxxx Xxxx & Xxxxx LLP
Convertible Arbitrage Master Limited Xxxxxxx, XX 00000 000 Xxxxx Xxxxxx
Attn: Xxxxx Xxxxxxx Xxx Xxxx, Xxx Xxxx 00000
Fax: (000) 000-0000 Fax: (000) 000-0000
Telephone: (000) 000-0000
Attn: Xxxxxxx X. Xxxxx, Esq.
UBS X'Xxxxxx LLC fbo X'Xxxxxx Global One North Xxxxxx Drive 15,000 375,000.00 Xxxxxxx Xxxx & Xxxxx LLP
Convertible Arbitrage II Master Xxxxxxx, XX 00000 000 Xxxxx Xxxxxx
Limited Attn: Xxxxx Xxxxxxx Xxx Xxxx, Xxx Xxxx 00000
Fax: (000) 000-0000 Fax: (000) 000-0000
Telephone: (000) 000-0000
Attn: Xxxxxxx X. Xxxxx, Esq.
Silver Oak Capital, L.L.C. c/o Xxxxxx Xxxxxx & Co., LP 200,000 5,000,000.00
000 Xxxx Xxx., 00xx Xxxxx
Xxx Xxxx, XX 00000
Attn: Xxxx Xxxx
Fax: (000) 000-0000
Portside Growth and Opportunity Fund Ramius Capital Group 400,000 10,000,000.00
000 Xxxxx Xxxxxx, 00xx Xxxxx
Xxx Xxxx, XX 00000
Attn: Xxxx Xxxxx and Xxxx
Xxxxxxx
Fax: (000) 000-0000
Magnetar Capital Master Fund, Ltd c/o Magnetar Financial LLC 280,000 7,000,000.00 Xxxxxxx Xxxx & Xxxxx LLP
0000 Xxxxxxxxx Xxx., 00xx floor 000 Xxxxx Xxxxxx
Xxxxxxxx, XX 00000 Xxx Xxxx, Xxx Xxxx 00000
Attn: Xxxx Xxxxx, General Fax: (000) 000-0000
Counsel Telephone: (000) 000-0000
(000) 000-0000 Attn: Xxxxxxx X. Xxxxx, Esq.
Mac & Co Xxxxxxx Xxxxx & Company, LLC 14,796 369,900.00
000 X. Xxxxx Xx.
Xxxxxxx, XX 00000
Attn: Xxxxxxx Xxxxxx
Fax: (000) 000-0000
Xxxxxxx & Co Xxxxxxx Xxxxx & Company, LLC 5,410 135,250.00
FFC City of Dearborn Policemen and 000 X. Xxxxx Xx.
Firemen Revised Retirement Systems Xxxxxxx, XX 00000
Attn: Xxxxxxx Xxxxxx
Fax: (000) 000-0000
Xxxxxxx & Co Xxxxxxx Xxxxx & Company, LLC 3,395 84,875.00
FFC City of Dearborn General 000 X. Xxxxx Xx.
Employees Retirement Systems Xxxxxxx, XX 00000
Attn: Xxxxxxx Xxxxxx
Fax: (000) 000-0000
Xxxxxxx Xxxxx Small Cap Growth Fund Xxxxxxx Xxxxx & Company, LLC 548,973 13,724,325.00
000 X. Xxxxx Xx.
Xxxxxxx, XX 00000
Attn: Xxxxxxx Xxxxxx
Fax: (000) 000-0000
Booth & Co Xxxxxxx Xxxxx & Company, LLC 7,047 176,175.00
FFC Hartmarx Retirement Income Trust 000 X. Xxxxx Xx.
Xxxxxxx, XX 00000
Attn: Xxxxxxx Xxxxxx
Fax: (000) 000-0000
A-2
Booth & Co Xxxxxxx Xxxxx & Company, LLC 9,245 231,125.00
FFC Rush University Medical Center 000 X. Xxxxx Xx.
Xxxxxxxxx Account Xxxxxxx, XX 00000
Attn: Xxxxxxx Xxxxxx
Fax: (000) 000-0000
Booth & Co Xxxxxxx Xxxxx & Company, LLC 11,134 278,350.00
FFC Rush University Medical Center 000 X. Xxxxx Xx.
Pension and Retirement Xxxxxxx, XX 00000
Attn: Xxxxxxx Xxxxxx
Fax: (000) 000-0000
Capital Ventures International c/o Heights Capital Management 250,000 6,250,000.00
000 Xxxxxxxxxx Xxxxxx, Xxxxx 0000
Xxx Xxxxxxxxx, XX 00000
Attn: Xxx Xxxxx
Fax: (000) 000-0000
Capital Ventures International c/o Heights Capital Management 250,000 6,250,000.00
000 Xxxxxxxxxx Xxxxxx, Xxxxx 0000
Xxx Xxxxxxxxx, XX 00000
Attn: Xxx Xxxxx
Fax: (000) 000-0000
Enable Growth Partners LP Xxx Xxxxx Xxxxxxxx, Xxxxx 000 000,000 8,500,000.00
Xxx Xxxxxxxxx, XX 00000
Attn: Xxxxxxx X'Xxxx
Fax: (000) 000-0000
Xxxxxx Diversified Strategy Master One Ferry Building, Suite 225 20,000 500,000.00
Fund LLC, Ena Xxx Xxxxxxxxx, XX 00000
Attn: Xxxxxxx X'Xxxx
Fax: (000) 000-0000
Enable Opportunity Partners LP One Ferry Building, Suite 225 40,000 1,000,000.00
Xxx Xxxxxxxxx, XX 00000
Attn: Xxxxxxx X'Xxxx
Fax: (000) 000-0000
Highbridge International LLC x/x Xxxxxxxxxx Xxxxxxx 000,000 5,000,000.00
Management, LLC
0 Xxxx 00xx Xx., 00xx Xxxxx
Xxx Xxxx, XX 00000
Attn: Xxx X. Xxxxxx /
Xxxx X. Chill
Fax: (000) 000-0000
Arkansas Teachers Retirement Systems 000 Xxxxxx Xxxxxx 22,700 567,500.00
Xxxxxx Xxxx, XX 00000
Attn: Xxxxxxx X. Xxxxx
Fax: (000) 000-0000
Arkansas Public Employees Retirement 000 Xxxxxx Xxxxxx 10,000 250,000.00
Systems Xxxxxx Xxxx, XX 00000
Attn: Xxxxxxx X. Xxxxx
Fax: (000) 000-0000
Baptist Health Springhill 000 Xxxxxx Xxxxxx 1,300 32,500.00
Xxxxxx Xxxx, XX 00000
Attn: Xxxxxxx X. Xxxxx
Fax: (000) 000-0000
Baptist Health HELP 000 Xxxxxx Xxxxxx 870 21,750.00
Xxxxxx Xxxx, XX 00000
Attn: Xxxxxxx X. Xxxxx
Fax: (000) 000-0000
A-3
Xxxxxxxx Group Inc. 000 Xxxxxx Xxxxxx 250 6,250.00
Xxxxxx Xxxx, XX 00000
Attn: Xxxxxxx X. Xxxxx
Fax: (000) 000-0000
Xxxxxxxx Investment Holdings, LLC 000 Xxxxxx Xxxxxx 3,500 87,500.00
Xxxxxx Xxxx, XX 00000
Attn: Xxxxxxx X. Xxxxx
Fax: (000) 000-0000
Xxxxxxx X. Xxxxxxxx Trust UID March 000 Xxxxxx Xxxxxx 1,100 27,500.00
22, 0000 Xxxxxx Xxxx, XX 00000
Attn: Xxxxxxx X. Xxxxx
Fax: (000) 000-0000
Xxxxxx and Xxxxxxx Xxxxxxxx 000 Xxxxxx Xxxxxx 650 16,250.00
Children's Trust UID Xxxxxx Xxxx, XX 00000
September 30, 1987 Xxx X. X. Xxxxxx Attn: Xxxxxxx X. Xxxxx
Trustee Fax: (000) 000-0000
Xxxxxxxx Small Cap Fund 000 Xxxxxx Xxxxxx 7,100 177,500.00
Xxxxxx Xxxx, XX 00000
Attn: Xxxxxxx X. Xxxxx
Fax: (000) 000-0000
St. Vincent's Foundation 000 Xxxxxx Xxxxxx 230 5,750.00
Xxxxxx Xxxx, XX 00000
Attn: Xxxxxxx X. Xxxxx
Fax: (000) 000-0000
S.A.C. Capital Associates, LLC c/o S.A.C. Capital Advisors, LLC 500,000 12,500,000.00
00 Xxxxxxxx Xxxxx Xxxx
Xxxxxxxx, XX 00000
Attn: Xxxxx X. Xxxxxxxx,
General Counsel
Fax: (000) 000-0000
Radcliffe SPC, Ltd. for and on behalf c/o RG Capital Management, L.P. 200,000 5,000,000.00
of the Class A Segregated Portfolio 0 Xxxx Xxxxx Xxxx, Xxxxx 000
Xxxx Xxxxxx, XX 00000
Attn: Xxxxxx X. Xxxxxxxxxx,
Managing Director
Fax: (000) 000-0000
Xxxxxx Bay Fund LP 000 Xxxxxxxx, 00xx Xxxxx 90,000 2,250,000.00
Xxx Xxxx, XX 00000
Attn: Xxxx Xxxx
Fax: (000) 000-0000
Xxxxxx Bay Overseas Fund LTD 000 Xxxxxxxx, 00xx Xxxxx 110,000 2,750,000.00
Xxx Xxxx, XX 00000
Attn: Xxxx Xxxx
Fax: (000) 000-0000
A-4
EXHIBIT B
EURONET WORLDWIDE, INC.
FORM OF REGISTRATION STATEMENT NOTICE AND QUESTIONNAIRE
The undersigned beneficial holder of the common stock, $.02 par value,
issuable pursuant to the Securities Purchase Agreement dated March 8, 2007
between Euronet Worldwide, Inc. ("Euronet Worldwide, Inc." or "Registrant") and
the purchasers named therein (the "Securities Purchase Agreement") (the
"Registrable Securities") understands that the Registrant has filed or intends
to file with the Securities and Exchange Commission (the "Commission") a
registration statement on Form S-3 (the "Shelf Registration Statement") for the
registration and resale under Rule 415 of the Securities Act of 1933, as amended
(the "Securities Act"), of the Registrable Securities, in accordance with the
terms of the Securities Purchase Agreement. Each capitalized term not otherwise
defined herein shall have the meaning ascribed thereto in the Securities
Purchase Agreement.
Each beneficial owner of Registrable Securities is entitled to the benefits
of the Securities Purchase Agreement. In order to sell or otherwise dispose of
any Registrable Securities pursuant to the Shelf Registration Statement, a
beneficial owner of Registrable Securities generally will be required to be
named as a selling securityholder in the related prospectus, deliver a
prospectus to purchasers of Registrable Securities and be bound by those
provisions of the Securities Purchase Agreement applicable to such beneficial
owner (including certain indemnification provisions, as described below). In
order to be named as a selling securityholder in the related prospectus, each
beneficial owner will be required to deliver certain information to be used in
connection with the registration statement. Beneficial owners are required to
complete and deliver this Notice and Questionnaire in connection with the
closing of the Securities Purchase Agreement so that such beneficial owners may
be named as selling securityholders in the related prospectus at the time of
effectiveness. Any beneficial owner of Registrable Securities wishing to include
its Registrable Securities must deliver to Euronet Worldwide, Inc. at the
address set forth herein a properly completed and signed Notice and
Questionnaire prior to the closing of the Securities Purchase Agreement. Euronet
Worldwide, Inc. has agreed to pay liquidated damages pursuant to the Securities
Purchase Agreement under certain circumstances as set forth therein.
Certain legal consequences arise from being named as a selling
securityholder in the Shelf Registration Statement and the related prospectus.
Accordingly, holders and beneficial owners of Registrable Securities are advised
to consult their own securities law counsel regarding the consequences of being
named or not being named as a selling securityholder in the Shelf Registration
Statement and the related prospectus.
NOTICE
The undersigned beneficial owner (the "Selling Securityholder") of
Registrable Securities hereby gives notice to Euronet Worldwide, Inc. of its
intention to sell or otherwise dispose of Registrable Securities beneficially
owned by it and listed below in Item 3 (unless otherwise specified under Item 3)
pursuant to the Shelf Registration Statement. The undersigned, by signing and
returning this Notice and Questionnaire, understands that it will be bound by
the terms and conditions of this Notice and Questionnaire and the Securities
Purchase Agreement
Pursuant to the Securities Purchase Agreement, the undersigned has agreed to
indemnify and hold harmless the directors and officers of Euronet Worldwide,
Inc. and each person, if any, who controls Euronet Worldwide, Inc. within the
meaning of either Section 15 of the Securities Act or Section 20 of the
Securities Exchange Act of 1934, as amended (the "Exchange Act"), from and
against certain losses arising in connection with statements concerning the
undersigned made in the Shelf Registration Statement or the related prospectus
in reliance upon the information provided in this Notice and Questionnaire.
The undersigned hereby provides the following information to Euronet
Worldwide, Inc. and represents and warrants that such information is accurate
and complete:
B-1
QUESTIONNAIRE
1. (a) Full legal name of Selling Securityholder:
--------------------------------------------------------------
--------------------------------------------------------------
(b) Full legal name of registered holder (if not the same as (a) above)
through which Registrable Securities listed in Item 3 below are held:
--------------------------------------------------------------
--------------------------------------------------------------
(c) Full legal name of Natural Control Person (which means a natural
person who directly or indirectly alone or with others has power to
vote or dispose of the securities covered by the questionnaire):
--------------------------------------------------------------
--------------------------------------------------------------
2. Address for notices to Selling Securityholder:
--------------------------------------------------------------
--------------------------------------------------------------
--------------------------------------------------------------
--------------------------------------------------------------
Telephone:
----------------------------------------------------
--------------------------------------------------------------
Fax:
---------------------------------------------------------
--------------------------------------------------------------
Email:
--------------------------------------------------------
--------------------------------------------------------------
Contact Person:
----------------------------------------------
--------------------------------------------------------------
3. Beneficial ownership of Registrable Securities:
(a) Number of shares of Registrable Securities beneficially owned:
(b) CUSIP No(s). of such Registrable Securities beneficially owned:
4. Beneficial ownership of other securities of Euronet Worldwide, Inc. owned
by the Selling Securityholder:
Except as set forth below in this Item 4, the undersigned is not the
beneficial or registered owner of any securities of Euronet Worldwide,
Inc. other than the Registrable Securities listed above in Item 3.
(a) Type and amount of other securities beneficially owned by the Selling
Securityholder:
B-2
--------------------------------------------------------------
--------------------------------------------------------------
--------------------------------------------------------------
--------------------------------------------------------------
(b) CUSIP No(s). of such other securities beneficially owned:
--------------------------------------------------------------
--------------------------------------------------------------
5. Relationships with Euronet Worldwide, Inc.:
Except as set forth below, neither the undersigned nor any of its
affiliates, officers, directors or principal equity holders (5% or
more) has held any position or office or has had any other material
relationship with Euronet Worldwide, Inc. (or its predecessors or
affiliates) during the past three years. State any exceptions here:
--------------------------------------------------------------
--------------------------------------------------------------
--------------------------------------------------------------
--------------------------------------------------------------
6. Broker-Dealer Status.
(a) Is the Selling Securityholder a broker-dealer?
Yes |_| No |_|
(b) If the answer to Item 6(a) is "Yes", you must answer the following:
State whether the Selling Securityholder obtained the Registrable
Securities as compensation for underwriting services, and if so,
provide a brief description of the transaction(s).
--------------------------------------------------------------
--------------------------------------------------------------
--------------------------------------------------------------
--------------------------------------------------------------
NOTE:If the Selling Securityholder is a broker-dealer, the Selling
Securityholder will be identified as an underwriter in the Shelf
Registration Statement as required by the Commission staff, unless the
Selling Securityholder obtained the Registrable Securities as
compensation for underwriting services.
7. Broker-Dealer Affiliate Status.
(a) Is the Selling Securityholder an affiliate of a broker-dealer?
Yes |_| No |_|
If "Yes", provide the names of broker-dealers with whom the
Selling Securityholder is affiliated:
--------------------------------------------------------------
--------------------------------------------------------------
--------------------------------------------------------------
--------------------------------------------------------------
(b) If the answer to Item 7(a) is "Yes", you must answer the following:
B-3
Did the Selling Securityholder (i) purchase the Registrable
Securities in the ordinary course of business and (ii) at the
time of the purchase, have no agreements or understandings,
directly or indirectly, with any person to distribute the
Registrable Securities?
Yes |_| No |_|
NOTE: If the Selling Securityholder is an affiliate of a broker-dealer and
answered "No" to Item 7(b), the Selling Securityholder will be
identified as an underwriter in the Shelf Registration Statement as
required by the Commission staff.
8. Plan of Distribution:
Except as set forth below, the undersigned (including its donees or
pledgees) intends to distribute the Registrable Securities listed above in
Item 3 pursuant to the Shelf Registration Statement only as follows: Such
Registrable Securities may be sold from time to time directly by the
undersigned or, alternatively, through underwriters, broker-dealers or
agents. If the Registrable Securities are sold through underwriters or
broker-dealers, the Selling Securityholder will be responsible for
underwriting discounts or commissions or agent's commissions. Such
Registrable Securities may be sold in one or more transactions at fixed
prices, at prevailing market prices at the time of sale, at varying prices
determined at the time of sale, or at negotiated prices. Such sales may be
effected in transactions (which may involve block transactions) (i) on any
national securities exchange or quotation service on which the Registrable
Securities may be listed or quoted at the time of sale, (ii) in the
over-the-counter market, or (iii) in transactions otherwise than on such
exchanges or services or in the over-the-counter market. The Selling
Securityholder may pledge or grant a security interest in some or all of
the Registrable Securities owned by it and, if it defaults in the
performance of its secured obligations, the pledgees or secured parties may
offer and sell the Registrable Securities from time to time pursuant to the
prospectus. The Selling Securityholder also may transfer and donate
Registrable Securities in other circumstances in which case the
transferees, donees, pledgees or other successors in interest will be the
selling securityholder for purposes of the prospectus.
State any exceptions here:
-----------------------------------
--------------------------------------------------------------
--------------------------------------------------------------
--------------------------------------------------------------
Note: In no event will such method(s) of distribution take the form of
an underwritten offering of the Registrable Securities without the
prior agreement of Euronet Worldwide, Inc.
The undersigned acknowledges that it understands its obligation to comply
with the provisions of the Exchange Act and the rules thereunder relating to
stock manipulation, particularly Regulation M thereunder (or any successor rules
or regulations) and the provisions of the Securities Act relating to prospectus
delivery, in connection with any offering of Registrable Securities pursuant to
the Shelf Registration Statement. The undersigned agrees that neither it nor any
person acting on its behalf will engage in any transaction in violation of such
provisions.
The Selling Securityholder hereby acknowledges its obligations under the
Securities Purchase Agreement to indemnify and hold harmless certain persons as
set forth therein.
Pursuant to the Securities Purchase Agreement, Euronet Worldwide, Inc. has
agreed under certain circumstances to indemnify the Selling Securityholder
against certain liabilities.
In accordance with the undersigned's obligation under the Securities
Purchase Agreement to provide such information as may be required by law for
inclusion in the Shelf Registration Statement, the undersigned agrees to
promptly notify Euronet Worldwide, Inc. of any inaccuracies or changes in the
information provided herein that may occur subsequent to the date hereof at any
time while the Shelf Registration Statement remains effective. All notices
hereunder and pursuant to the Securities Purchase Agreement shall be made in
writing at the address set forth below.
In the event that the undersigned transfers all or any portion of the
Registrable Securities listed in Item 3 above after the date on which such
information is provided to Euronet Worldwide, Inc., the undersigned agrees to
B-4
notify the transferee(s) at the time of transfer of its rights and obligations
under this Notice and Questionnaire and the Securities Purchase Agreement.
By signing below, the undersigned consents to the disclosure of the
information contained herein in, its answers to Items 1 through 8 above and the
inclusion of such information in the Shelf Registration Statement and the
related prospectus. The undersigned understands that such information will be
relied upon by Euronet Worldwide, Inc. in connection with the preparation of the
Shelf Registration Statement and the related prospectus and any amendments or
supplements thereto.
By signing below, subject to the terms of the Securities Purchase
Agreement, the undersigned agrees that if Euronet Worldwide, Inc. notifies the
undersigned that the Shelf Registration Statement is not available, the
undersigned will suspend use of the prospectus until receipt of notice from
Euronet Worldwide, Inc. that the prospectus is again available.
If the undersigned has provided an email address in Item 2 above, by
signing below, the undersigned consents, with respect to all future notices and
communications required to be given to the undersigned under the Securities
Purchase Agreement, to the giving of such notices and communications to the
undersigned by email at such email address set forth in Item 2 above.
Once this Notice and Questionnaire is executed by the undersigned and
received by Euronet Worldwide, Inc., the terms of this Notice and Questionnaire,
and the representations and warranties contained herein, shall be binding on,
shall inure to the benefit of and shall be enforceable by the respective
successors, heirs, personal representatives, and assigns of Euronet Worldwide,
Inc. and the undersigned with respect to the Registrable Securities beneficially
owned by the undersigned and listed in Item 3 above. This Notice and
Questionnaire shall be governed in all respects by the laws of the State of New
York.
IN WITNESS WHEREOF, the undersigned, by authority duly given, has caused
this Notice and Questionnaire to be executed and delivered either in person or
by its duly authorized agent.
Date:
---------------------------
Beneficial Owner
By:
----------------------
Name:
----------------------
Title:
----------------------
PLEASE RETURN THE COMPLETED AND EXECUTED NOTICE AND
QUESTIONNAIRE TO EURONET WORLDWIDE, INC. AT:
Euronet Worldwide, Inc.
0000 Xxxxxxx Xxxxxxxxx
Xxxxxxx, XX 00000
Attn: Xxxxxxx X. Xxxxxx
B-5
EXHIBIT C-1
FORM OF OPINION OF XXXXXXX XXXXXXXX XXXXXX LLP
----------------------------------------------
(i) The execution and delivery of the Securities Purchase Agreement and the
issuance of the Shares by the Company and the performance by the Company of its
obligations thereunder have been duly authorized, executed and delivered by, and
the Securities Purchase Agreement is a valid and binding agreement of, the
Company, enforceable in accordance with its terms, except as rights to
indemnification thereunder may be limited by applicable law and except as the
enforcement thereof may be limited by bankruptcy, insolvency, reorganization,
receivership, arrangement, moratorium, assignment for the benefit of creditors
or other similar laws relating to or affecting creditors' rights generally or by
general equitable principles.
(ii) The Shares have been duly authorized by the Company and, when issued,
delivered and paid for in accordance with the Securities Purchase Agreement,
will be validly issued, fully paid and non-assessable. The issuance and sale of
the Shares is not subject to any preemptive right under the Delaware General
Corporation Law or the Company's certificate of incorporation, or the by-laws of
the Company or similar contractual rights under any Material Agreements, except
for any such preemptive or contractual rights that have been waived.
(iii)The execution and delivery of the Securities Purchase Agreement and
the issuance of the Shares by the Company and the performance by the Company of
its obligations thereunder (other than performance by the Company of its
obligations under the indemnification section of the Securities Purchase
Agreement, as to which no opinion need be rendered) (A) will not result in any
violation of the provisions of the charter or by-laws of the Company; (B) will
not conflict with or constitute a breach of, or default under, or result in the
creation or imposition of any lien, charge or encumbrance upon any property or
assets of the Company or any of its subsidiaries pursuant to, or require the
consent of any other party to, any Material Agreement, or (C) will not result in
any violation of any U.S. federal or State of Kansas law or administrative
regulation or, to the knowledge of such counsel, administrative or court decree
applicable to the Company or any subsidiary.
(iv) The Company is not, and after giving effect to the offering of the
Shares and application of the proceeds will not be, required to register as an
"investment company" within the meaning of the Investment Company Act.
(v) The rights evidenced by such Shares, to the extent provided in the
Rights Agreement dated as of March 21, 2003 between the Company and EquiServe
Trust Company, N.A., as amended (the "Rights Agreement") have been duly
authorized and, when and if issued in accordance with the terms of the Rights
Agreement, will have been validly issued.
C-1-1
Capitalized terms used herein without definition shall have the respective
meanings ascribed to them in the Securities Purchase Agreement.
C-1-2
EXHIBIT C-2
FORM OF OPINION OF THE GENERAL COUNSEL
--------------------------------------
(i) The Company has been duly incorporated and is validly existing as a
corporation in good standing under the laws of the State of Delaware.
(ii) The Company has corporate power and authority to own, lease and
operate its properties and to conduct its business as described in the SEC
Documents and to enter into and perform its obligations under the Securities
Purchase Agreement.
(iii) The Company is duly qualified as a foreign corporation to transact
business and is in good standing in each jurisdiction in which such
qualification is required, whether by reason of the ownership or leasing of
property or the conduct of business, except for such jurisdictions where the
failure to so qualify or to be in good standing would not, individually or in
the aggregate, result in a Material Adverse Effect.
(iv) Each subsidiary of the Company has been duly incorporated and is
validly existing as a corporation in good standing under the laws of the
jurisdiction of its incorporation, has corporate power and authority to own,
lease and operate its properties and to conduct its business as described in SEC
Documents and, to the knowledge of such counsel, is duly qualified as a foreign
corporation to transact business and is in good standing in each jurisdiction in
which such qualification is required, whether by reason of the ownership or
leasing of property or the conduct of business, except for such jurisdictions
where the failure to so qualify or to be in good standing would not,
individually or in the aggregate, result in a Material Adverse Effect.
(v) The authorized capital stock of the company as of December 31, 2006
consisted of 90,000,000 shares of common stock, $0.02 par value, of which
37,245,861 shares were issued and outstanding, and 10,000,000 shares of
preferred stock, $0.02 par value, none of which have been issued.
(vi) After due inquiry, such counsel does not know of any legal or
governmental actions, suits or proceedings pending or, to such counsel's
knowledge, threatened against or affecting the Company or any of its
subsidiaries, where in any such case (A) there is a reasonable possibility that
such action, suit or proceeding might be determined adversely to the Company or
such subsidiary and (B) if such action, suit or proceeding were so determined
adversely, would reasonably be expected to adversely affect the consummation of
the transactions contemplated by the Securities Purchase Agreement.
(vii) No consent, approval, authorization or order of, or registration or
filing with, any court or other governmental or regulatory authority or agency
is required for the consummation of the transactions contemplated by the
issuance and sale of the Shares pursuant to the Securities Purchase Agreement,
or the execution, delivery and performance of the Company's obligations under
the Securities Purchase Agreement,
C-2-1
except as required under the Securities Act, applicable state securities or blue
sky laws (as to which such counsel does not express an opinion) and from the
NASD.
(viii) All of the outstanding shares of Common Stock have been duly
authorized and validly issued, are fully paid and non-assessable and, to such
counsel's knowledge, have been issued in compliance with the registration and
qualification requirements of federal and state securities laws.
(ix) The Company and each subsidiary possess such valid and current
certificates, authorizations or permits issued by the appropriate state, federal
or foreign regulatory agencies or bodies necessary to conduct their respective
businesses, and, to such counsel's knowledge, neither the Company nor any
subsidiary has received any notice of proceedings relating to the revocation or
modification of any such certificate, authorization or permit which, singly or
in the aggregate, if the subject of an unfavorable decision, ruling or finding,
could result in a Material Adverse Effect.
(x) Except as disclosed in the SEC Documents, the Company and its
subsidiaries own or possess sufficient Intellectual Property Rights reasonably
necessary to conduct their business as now conducted; and the expected
expiration of any of such Intellectual Property Rights would not, singly or in
the aggregate, result in a Material Adverse Effect. To such counsel's knowledge,
neither the Company nor any of its subsidiaries has received any notice of
infringement or conflict with, and to such counsel's knowledge, there is no
infringement of or conflict with, asserted Intellectual Property Rights of
others, which infringement or conflict, if the subject of an unfavorable
decision, would, singly or in the aggregate, result in a Material Adverse
Effect. The Company is not a party to or bound by any options, licenses or
agreements with respect to the Intellectual Property Rights of any other person
or entity that are required to be set forth in the SEC Documents and are not
described in all material respects. To such counsel's knowledge, none of the
technology employed by the Company has been obtained or is being used by the
Company in violation of any contractual obligation binding on the Company or any
of its officers, directors or employees or otherwise in violation of the rights
of any persons.
(xi) No stockholder of the Company or any other person has any preemptive
right, right of first refusal or, except as disclosed in the SEC Documents,
other similar right to subscribe for or purchase securities of the Company
arising (i) by operation of the charter or by-laws of the Company or the General
Corporation Law of the State of Delaware or (ii) to the best knowledge of such
counsel, otherwise.
(xii)To such counsel's knowledge, neither the Company nor any subsidiary is
in violation of its charter or by-laws or any law, administrative regulation or
administrative or court decree applicable to the Company or any subsidiary or is
in Default in the performance or observance of any obligation, agreement,
covenant or condition contained in any Material Agreement, except in each such
case for such violations or Defaults as would not, singly or in the aggregate,
result in a Material Adverse Effect.
C-2-1
Capitalized terms used herein without definition shall have the respective
meanings ascribed to them in the Securities Purchase Agreement.
C-2-3
Schedule 1
Use of Proceeds Disclosure
--------------------------
The Company currently anticipates using the proceeds from the private
placement for future acquisitions and other general corporate purposes. One of
the acquisition candidates being considered, which is complimentary to one of
the Company's divisions, would represent a significant acquisition for the
Company. That particular candidate is running an auction process and the Company
is considering whether to submit a bid, which would only be made if it is with a
strategic joint venture partner. If such a joint venture is formed and is the
successful bidder in that auction, the Company's part of the consideration would
include cash and assumption of liabilities and would be funded through a
combination of the proceeds of this offering and available cash and potential
borrowings. The financial impact of this acquisition on the Company is difficult
to predict because it would depend on the purchase price, the cost of any debt
acquisition financing, the synergies and other financial benefits from the
acquisition and the structure of the joint venture. Accordingly, it is possible
that the transaction may be dilutive to the Company's earnings per share in the
early term of the investment. There can be no assurance that the Company will
make a bid in the auction, or if made, that the Company will be successful in
completing the transaction.
Until the proceeds are utilized as described above, they will be
invested in short term investments. Therefore, while so invested and based on
current short term interest rates, this offering is not expected to result in
dilution to the Company's first quarter 2007 earnings per share as discussed in
the Company's press release dated February 20, 2007.
C-2-4
